HGID,LOT_ID,Canonical_smiles,MW,Target,Value_type,Value,Unit,Relation,Value_comments,Conc_uM,Recovery_rate,Assay_type,Assay_name,Cell_line,Organism,Data_source
HG-0306868,HG-0306868-0-00,CC(Oc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C(=O)N(C)CCO,452.503,CAB2,Inhibition,,%,,Not Active,2.4,,patch clamp,Inhibition of human CACNB2 channel expressed in CHO cells at 20.4 +/- 2.4 uM by patch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0332317,HG-0332317-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC4,323.392,CACNA2D1,IC50,1,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332316,HG-0332316-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCCC4,337.419,CACNA2D1,IC50,2,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332325,HG-0332325-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(N)C4,352.433,CACNA2D1,IC50,2,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332314,HG-0332314-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(F)C4,355.409,CACNA2D1,IC50,3,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332334,HG-0332334-0-00,Cc1nnc(N2CCCC2)c3nn(c(C)c13)c4ccc(Cl)cc4OC(F)(F)F,411.809,CACNA2D1,IC50,3,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332333,HG-0332333-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CC(C4)OC,353.418,CACNA2D1,IC50,5,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332326,HG-0332326-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(O)C4,353.418,CACNA2D1,IC50,5,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332332,HG-0332332-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(C4)OC,367.445,CACNA2D1,IC50,6,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332319,HG-0332319-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N(C)C,311.382,CACNA2D1,IC50,7,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0310726,HG-0310726-0-00,COC1CN(C1)c2nnc(C)c3c(C)n(nc23)c4ccc(Cl)cc4OC(F)(F)F,427.808,CACNA2D1,IC50,8,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0310790,HG-0310790-0-00,CCOc1ccc(c(F)c1)n2nc3c(nnc(C)c3c2C)N4CC(C4)OC,371.409,CACNA2D1,IC50,8,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332223,HG-0332223-0-00,CCCC(CCCN(CC)CC)Nc1c2ccccc2nc3ccccc13,363.539,CACNA2D1,IC50,9,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332248,HG-0332248-0-00,Cc1cccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)c1,492.496,CACNA2D1,IC50,15,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332223,HG-0332223-0-00,CCCC(CCCN(CC)CC)Nc1c2ccccc2nc3ccccc13,363.539,CACNA2D1,IC50,18,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332265,HG-0332265-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc(F)c4)c3c2C,404.48,CACNA2D1,IC50,18,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332329,HG-0332329-0-00,Cc1nnc(N2CCCC2)c3nn(c(C)c13)c4ccc(OCC(F)(F)F)cc4,391.39,CACNA2D1,IC50,20,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332322,HG-0332322-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCCCCC4,365.472,CACNA2D1,IC50,22,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332318,HG-0332318-0-00,CCOc1ccc(cc1)n2nc3c(NC)nnc(C)c3c2C,297.355,CACNA2D1,IC50,22,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332335,HG-0332335-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(F)(F)C4,373.4,CACNA2D1,IC50,25,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332336,HG-0332336-0-00,Cc1nnc(N2CCCC2)c3nn(c(C)c13)c4ccc(Cl)cc4Cl,362.256,CACNA2D1,IC50,25,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0009229,HG-0009229-0-00,NCC1(CC(=O)O)CCCCC1,171.237,CACNA2D1,IC50,27,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332284,HG-0332284-0-00,CC(NCCc1cccc(Br)c1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,571.392,CACNA2D1,IC50,28,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332312,HG-0332312-0-00,CC(NCCc1cccc(C)c1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,506.522,CACNA2D1,IC50,29,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332234,HG-0332234-0-00,CC(NCCc1ccccc1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,30,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332337,HG-0332337-0-00,[3H]c1cccc(CCNC(C)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)c1,494.504,CACNA2D1,IC50,30,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332268,HG-0332268-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc5[nH]ccc5c4)c3c2C,411.499,CACNA2D1,IC50,30,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332327,HG-0332327-0-00,CC(C)Oc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCCC4,351.445,CACNA2D1,IC50,32,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332254,HG-0332254-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccc5CCCNc5n4)c3c2C,442.556,CACNA2D1,IC50,32,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0310943,HG-0310943-0-00,Cc1nnc(N2CCC(F)C2)c3nn(c(C)c13)c4ccc(OCC(F)(F)F)cc4,409.381,CACNA2D1,IC50,32,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332320,HG-0332320-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCC(O)CC4,367.445,CACNA2D1,IC50,32,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332234,HG-0332234-0-00,CC(NCCc1ccccc1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,36,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332255,HG-0332255-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc5[nH]ncc5c4)c3c2C,412.487,CACNA2D1,IC50,36,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332258,HG-0332258-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc(Cl)c4)c3c2C,420.934,CACNA2D1,IC50,37,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332222,HG-0332222-0-00,CCC(CCCN(CC)CC)Nc1c2ccccc2nc3ccccc13,349.512,CACNA2D1,IC50,38,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332279,HG-0332279-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NC)c3c2C,310.393,CACNA2D1,IC50,40,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332321,HG-0332321-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCCCC4,351.445,CACNA2D1,IC50,42,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332219,HG-0332219-0-00,CCN(CC)CCCC(C)Nc1c2CCCCc2nc3CCCCc13,343.549,CACNA2D1,IC50,43,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332342,HG-0332342-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCC4CCCO4)c3c2C,380.483,CACNA2D1,IC50,50,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332283,HG-0332283-0-00,CCN(CC)CCCC(Nc1c2ccccc2nc3ccccc13)C4CC4,361.523,CACNA2D1,IC50,52,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332303,HG-0332303-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NC4CCc5ccccc45)c3c2C,412.527,CACNA2D1,IC50,54,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332324,HG-0332324-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCCNCC4,366.46,CACNA2D1,IC50,58,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332257,HG-0332257-0-00,CCCCNc1nnc(C)c2c(C)n(c(C)c12)c3ccc(OCC)cc3,352.473,CACNA2D1,IC50,61,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332304,HG-0332304-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc5cccnc45)c3c2C,437.536,CACNA2D1,IC50,63,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332306,HG-0332306-0-00,CCOn1c(C)c2c(C)nnc(NNCc3cnn(CC)c3)c2c1C,343.427,CACNA2D1,IC50,64,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332269,HG-0332269-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccc(Cl)cc4)c3c2C,420.934,CACNA2D1,IC50,65,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332259,HG-0332259-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NC(C)C)c3c2C,338.447,CACNA2D1,IC50,67,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332298,HG-0332298-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4[nH]ncc4C5CC5)c3c2C,416.519,CACNA2D1,IC50,68,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332252,HG-0332252-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cnn(C)c4)c3c2C,390.481,CACNA2D1,IC50,69,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332260,HG-0332260-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc5[nH]ccc45)c3c2C,425.525,CACNA2D1,IC50,70,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332249,HG-0332249-0-00,FC(F)(F)c1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,478.469,CACNA2D1,IC50,72,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332338,HG-0332338-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccccc4)c3c2C,372.463,CACNA2D1,IC50,75,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332267,HG-0332267-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccccc4OC)c3c2C,416.515,CACNA2D1,IC50,76,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332328,HG-0332328-0-00,Cc1nnc(N2CCCC2)c3nn(c(C)c13)c4ccc(OC(F)(F)F)cc4,377.364,CACNA2D1,IC50,79,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332297,HG-0332297-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CC5CCc6ccccc6C5C4)c3c2C,452.591,CACNA2D1,IC50,84,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332300,HG-0332300-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccncc4)c3c2C,387.477,CACNA2D1,IC50,84,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332253,HG-0332253-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCC(C)CC)c3c2C,366.5,CACNA2D1,IC50,84,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332296,HG-0332296-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc(C)n4)c3c2C,401.504,CACNA2D1,IC50,84,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332339,HG-0332339-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(C)cc4)c3c2C,371.475,CACNA2D1,IC50,86,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332261,HG-0332261-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccc(F)cc4)c3c2C,404.48,CACNA2D1,IC50,94,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332194,HG-0332194-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(CC)cc4)c3c2C,385.501,CACNA2D1,IC50,107,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332216,HG-0332216-0-00,CCN(CC)CCCC(C)Nc1c2ccccc2nc3ccccc13,335.486,CACNA2D1,IC50,110,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332287,HG-0332287-0-00,COc1cccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)c1,508.495,CACNA2D1,IC50,116,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332256,HG-0332256-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccnc4)c3c2C,387.477,CACNA2D1,IC50,119,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332330,HG-0332330-0-00,COC1CN(C1)c2nnc(C)c3c(C)n(nc23)c4ccc(OCC(F)(F)F)cc4,407.39,CACNA2D1,IC50,126,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332245,HG-0332245-0-00,COCc1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,454.524,CACNA2D1,IC50,131,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332250,HG-0332250-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCC5=C(C4)NC6C=CC=CC56)c3c2C,453.579,CACNA2D1,IC50,135,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332293,HG-0332293-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCC(C4)NC(=O)C)c3c2C,407.509,CACNA2D1,IC50,144,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332239,HG-0332239-0-00,C(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)C6CCCCC6)n2,492.615,CACNA2D1,IC50,145,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332242,HG-0332242-0-00,Cc1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,424.498,CACNA2D1,IC50,145,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332204,HG-0332204-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CCC4CCCC4)c3c2C,377.522,CACNA2D1,IC50,148,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332294,HG-0332294-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCC(C4)(c5ccccc5)c6ccccc6)c3c2C,502.649,CACNA2D1,IC50,153,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332340,HG-0332340-0-00,CCOc1ccc(cc1)c2nnc(C)c3c(C)n(c(C)c23)c4ccc(OCC)cc4,401.501,CACNA2D1,IC50,153,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332198,HG-0332198-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(OC)cc4)c3c2C,387.474,CACNA2D1,IC50,154,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332219,HG-0332219-0-00,CCN(CC)CCCC(C)Nc1c2CCCCc2nc3CCCCc13,343.549,CACNA2D1,IC50,160,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332237,HG-0332237-0-00,Fc1cccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)c1,496.46,CACNA2D1,IC50,161,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332263,HG-0332263-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NC4CCCc5ccccc45)c3c2C,426.553,CACNA2D1,IC50,161,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332315,HG-0332315-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCN(C)CC4,366.46,CACNA2D1,IC50,169,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332201,HG-0332201-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N(C)C)c3c2C,324.42,CACNA2D1,IC50,170,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332215,HG-0332215-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(C4CC4)c3c2C,321.416,CACNA2D1,IC50,170,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332209,HG-0332209-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CC(C)C)c3c2C,337.459,CACNA2D1,IC50,171,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332344,HG-0332344-0-00,CC(C)C(NCCc1ccccc1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,520.549,CACNA2D1,IC50,174,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332262,HG-0332262-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N(C)CCc4ccccn4)c3c2C,415.531,CACNA2D1,IC50,179,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332291,HG-0332291-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCCC4)c3c2C,350.457,CACNA2D1,IC50,180,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332211,HG-0332211-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(C)c3c2C,295.379,CACNA2D1,IC50,180,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332243,HG-0332243-0-00,CCC(NCCc1ccccc1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,506.522,CACNA2D1,IC50,183,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332341,HG-0332341-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(C4CCCC4)c3c2C,349.469,CACNA2D1,IC50,185,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332231,HG-0332231-0-00,CSc1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,456.563,CACNA2D1,IC50,194,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332285,HG-0332285-0-00,C(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)c6ccccc6)n2,486.567,CACNA2D1,IC50,195,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332235,HG-0332235-0-00,CC(CNCc1cccc(COc2nn3c(nnc3c4ccccc24)C(F)(F)F)n1)c5ccccc5,492.496,CACNA2D1,IC50,198,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332295,HG-0332295-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc5CCCc5c4)c3c2C,412.527,CACNA2D1,IC50,199,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332331,HG-0332331-0-00,COC1CN(C1)c2nnc(C)c3c(C)n(nc23)c4ccc(Cl)cc4Cl,378.256,CACNA2D1,IC50,200,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332299,HG-0332299-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc5OCOc5c4)c3c2C,416.472,CACNA2D1,IC50,207,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332206,HG-0332206-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CC4CCCC4)c3c2C,363.496,CACNA2D1,IC50,211,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332323,HG-0332323-0-00,CCOc1ccc(cc1)n2nc3c(nnc(C)c3c2C)N4CCNCC4,352.433,CACNA2D1,IC50,213,nM,=,,,,binding,Binding affinity at voltage-gated calcium channel subunit alpha2delta1,,Homo sapiens,ChEMBL
HG-0332241,HG-0332241-0-00,Cc1onc(c1)c2nnc3c4ccccc4c(OCc5cccc(CNCCc6ccccc6)n5)nn23,491.544,CACNA2D1,IC50,220,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332216,HG-0332216-0-00,CCN(CC)CCCC(C)Nc1c2ccccc2nc3ccccc13,335.486,CACNA2D1,IC50,220,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332305,HG-0332305-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCCCC4)c3c2C,364.484,CACNA2D1,IC50,221,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332288,HG-0332288-0-00,FC(F)(F)c1nnc2c3ccccc3c(OCc4cccc(CNC5CC5c6ccccc6)n4)nn12,490.48,CACNA2D1,IC50,229,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332232,HG-0332232-0-00,C(Cc1ccccc1)NCc2cccc(COc3nn4cnnc4c5ccccc35)n2,410.471,CACNA2D1,IC50,230,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332214,HG-0332214-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(C4CCCCC4)c3c2C,363.496,CACNA2D1,IC50,235,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332251,HG-0332251-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4cccc(OC)c4)c3c2C,416.515,CACNA2D1,IC50,239,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332205,HG-0332205-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc(C)cc4)c3c2C,386.489,CACNA2D1,IC50,240,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332311,HG-0332311-0-00,CCc1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,438.524,CACNA2D1,IC50,241,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332278,HG-0332278-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CC)c3c2C,309.405,CACNA2D1,IC50,250,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332240,HG-0332240-0-00,Cc1ccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)cc1,492.496,CACNA2D1,IC50,260,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332213,HG-0332213-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CCC(C)C)c3c2C,351.485,CACNA2D1,IC50,263,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332226,HG-0332226-0-00,CCN(CC)CCCC(C)(C)Nc1c2ccccc2nc3ccccc13,349.512,CACNA2D1,IC50,270,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332244,HG-0332244-0-00,C(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)C6CC6)n2,450.535,CACNA2D1,IC50,272,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332236,HG-0332236-0-00,Fc1ccccc1CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,496.46,CACNA2D1,IC50,291,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332292,HG-0332292-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NC(C)CC(C)C)c3c2C,380.526,CACNA2D1,IC50,296,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332210,HG-0332210-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4cccc(OC)c4)c3c2C,387.474,CACNA2D1,IC50,335,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332246,HG-0332246-0-00,CC(C)c1nnc2c3ccccc3c(OCc4cccc(CNCCc5ccccc5)n4)nn12,452.551,CACNA2D1,IC50,342,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332271,HG-0332271-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc5[nH]nnc5c4)c3c2C,413.475,CACNA2D1,IC50,346,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332199,HG-0332199-0-00,CCCCCc1nnc(C)c2c(C)n(c(C)c12)c3ccc(OCC)cc3,351.485,CACNA2D1,IC50,360,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332266,HG-0332266-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCC(C)CC4)c3c2C,378.51,CACNA2D1,IC50,370,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332276,HG-0332276-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccccc4)c3c2C,357.448,CACNA2D1,IC50,382,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332280,HG-0332280-0-00,CCN(CC)CCCC(C)Nc1c2CCCCc2nc3ccccc13,339.518,CACNA2D1,IC50,420,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332197,HG-0332197-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc(OC)cc4)c3c2C,402.489,CACNA2D1,IC50,440,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332247,HG-0332247-0-00,Cc1ccccc1CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,448,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332274,HG-0332274-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(F)cc4)c3c2C,375.439,CACNA2D1,IC50,528,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332195,HG-0332195-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(CC(C)CC(C)(C)C)c3c2C,393.565,CACNA2D1,IC50,577,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332272,HG-0332272-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(OC)cc4OC)c3c2C,417.5,CACNA2D1,IC50,597,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332310,HG-0332310-0-00,Fc1ccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)cc1,496.46,CACNA2D1,IC50,630,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332238,HG-0332238-0-00,CC(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,700,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332212,HG-0332212-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(Cl)cc4)c3c2C,391.893,CACNA2D1,IC50,701,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332270,HG-0332270-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CC(C)CC(C)C4)c3c2C,392.537,CACNA2D1,IC50,702,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332264,HG-0332264-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccc(OC)cc4)c3c2C,416.515,CACNA2D1,IC50,702,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332275,HG-0332275-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccccc4OC)c3c2C,387.474,CACNA2D1,IC50,737,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332219,HG-0332219-0-00,CCN(CC)CCCC(C)Nc1c2CCCCc2nc3CCCCc13,343.549,CACNA2D1,IC50,760,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332290,HG-0332290-0-00,COc1ccc(CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2)cc1,508.495,CACNA2D1,IC50,829,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332229,HG-0332229-0-00,CCN(CC)CCCC(C)Nc1cc(nc2ccccc12)c3ccccc3,361.523,CACNA2D1,IC50,960,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332225,HG-0332225-0-00,CCN(CC)CCCC(Nc1c2ccccc2nc3ccccc13)c4ccccc4,397.555,CACNA2D1,IC50,1100,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332207,HG-0332207-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(cc4)c5ccccc5)c3c2C,433.544,CACNA2D1,IC50,1263,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332238,HG-0332238-0-00,CC(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,1369,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332203,HG-0332203-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4cccc(Cl)c4)c3c2C,391.893,CACNA2D1,IC50,1597,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332343,HG-0332343-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCOCC4)c3c2C,366.457,CACNA2D1,IC50,1692,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332202,HG-0332202-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccc(OC(F)(F)F)cc4)c3c2C,441.446,CACNA2D1,IC50,1729,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332277,HG-0332277-0-00,CCOc1ccccc1n2c(C)c3c(C)nnc(C)c3c2C,295.379,CACNA2D1,IC50,1850,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332208,HG-0332208-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(OC)c3c2C,311.378,CACNA2D1,IC50,2181,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332301,HG-0332301-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CCN(C)CC4)c3c2C,379.499,CACNA2D1,IC50,2926,nM,=,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332302,HG-0332302-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(N4CC(C)OC(C)C4)c3c2C,394.51,CACNA2D1,IC50,3000,nM,>,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332307,HG-0332307-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(NCc4ccccn4)c3c2C,387.477,CACNA2D1,IC50,3000,nM,>,,,,binding,[3H]Gabapentin binding in human A710 membrane expressing alpha-2delta subunit of calcium channel,,Homo sapiens,ChEMBL
HG-0332286,HG-0332286-0-00,COc1ccccc1CCNCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,508.495,CACNA2D1,IC50,3163,nM,=,,,,binding,Binding affinity against alpha-2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human,,Homo sapiens,ChEMBL
HG-0332196,HG-0332196-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(c4ccccc4Cl)c3c2C,391.893,CACNA2D1,IC50,4367,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332220,HG-0332220-0-00,CC(C)NCCCC(C)Nc1c2ccccc2nc3ccccc13,321.459,CACNA2D1,IC50,5100,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332313,HG-0332313-0-00,CCCOc1ccc(cc1)n2c(C)c3c(C)nnc(C)c3c2C,309.405,CACNA2D1,IC50,5180,nM,=,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332281,HG-0332281-0-00,CC(CCCN1C(C)CCCC1C)Nc2c3ccccc3nc4ccccc24,375.55,CACNA2D1,IC50,5900,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332224,HG-0332224-0-00,CCN(CC)CCCCC(C)Nc1c2ccccc2nc3ccccc13,349.512,CACNA2D1,IC50,6000,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332282,HG-0332282-0-00,CC(CCCN1CCCC1)Nc2c3ccccc3nc4ccccc24,333.47,CACNA2D1,IC50,9900,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332309,HG-0332309-0-00,CCOc1cccc(c1)n2c(C)c3c(C)nnc(C)c3c2C,295.379,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332218,HG-0332218-0-00,CC(CCCN1CCOCC1)Nc2c3ccccc3nc4ccccc24,349.469,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332234,HG-0332234-0-00,CC(NCCc1ccccc1)c2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,10000,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332273,HG-0332273-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccc(N)cc4)c3c2C,387.477,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332228,HG-0332228-0-00,CCN(CC)CCC(C)Nc1c2ccccc2nc3ccccc13,321.459,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332308,HG-0332308-0-00,CCOc1ccc(cc1)n2c(C)c3c(C)nnc(Nc4ccncc4)c3c2C,373.451,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332227,HG-0332227-0-00,CC(CCCN(C(C)C)C(C)C)Nc1c2ccccc2nc3ccccc13,363.539,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332200,HG-0332200-0-00,COc1ccc(cc1)n2c(C)c3c(C)nnc(C)c3c2C,281.352,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity for huamn alpha2-delta1 subunit of voltage gated calcium channel over-expressed in A710 cell membranes using [3H]-gabapentin,A710,Homo sapiens,ChEMBL
HG-0332217,HG-0332217-0-00,CC(CCCN1CCCCC1)Nc2c3ccccc3nc4ccccc24,347.496,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332289,HG-0332289-0-00,CN(CCc1ccccc1)Cc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,492.496,CACNA2D1,IC50,10000,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332221,HG-0332221-0-00,CCN(CC)CCCC(C)Nc1cc(nc2CCCCc12)C(F)(F)F,357.457,CACNA2D1,IC50,10000,nM,>,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332233,HG-0332233-0-00,CC(C)(Cc1ccccc1)NCc2cccc(COc3nn4c(nnc4c5ccccc35)C(F)(F)F)n2,506.522,CACNA2D1,IC50,10000,nM,=,,,,binding,Binding affinity against alpha2 delta-1 subunit of voltage-gated calcium channel in human.,,Homo sapiens,ChEMBL
HG-0332216,HG-0332216-0-00,CCN(CC)CCCC(C)Nc1c2ccccc2nc3ccccc13,335.486,CACNA2D1,IC50,11000,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0332230,HG-0332230-0-00,CCN(CC)CCCCNc1c2ccccc2nc3ccccc13,321.459,CACNA2D1,IC50,13000,nM,=,,,,binding,Binding affinity towards alpha2-delta subunit of a voltage gated calcium channel using [3H]gabapentin in human brain membrane (A710 membrane),,Homo sapiens,ChEMBL
HG-0306868,HG-0306868-0-00,CC(Oc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C(=O)N(C)CCO,452.503,CACNA2D1,Inhibition,,%,,Not Active,2.4,,patch clamp,Inhibition of human CACNA2D1 channel expressed in CHO cells at 20.4 +/- 2.4 uM by patch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0331869,HG-0331869-0-00,NCC(=O)NC1C\C=C/CC2NC(=O)C(CCCN=C(N)N)NC(=O)C3CCCN3C(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CSSCC(NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc4ccc(O)cc4)NC(=O)C(CCCN=C(N)N)NC2=O)C(=O)NC(CCCN=C(N)N)C(=O)O)NC1=O,1532.71,CACNA2D1/Cav2.2/CAB3,Inhibition,,%,,Not Active,1,,patch clamp,Inhibition of human Cav2.2 alpha1B/alpha2delta1/beta3 channel expressed in HEK293 cells assessed as inhibition of depolarization-activated Ba2+ current at 1 uM by whole cell patch clamp technique relative to control,HEK293,Homo sapiens,ChEMBL
HG-0331869,HG-0331869-0-00,NCC(=O)NC1C\C=C/CC2NC(=O)C(CCCN=C(N)N)NC(=O)C3CCCN3C(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CSSCC(NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc4ccc(O)cc4)NC(=O)C(CCCN=C(N)N)NC2=O)C(=O)NC(CCCN=C(N)N)C(=O)O)NC1=O,1532.71,CACNA2D1/Cav2.2/CAB3,Inhibition,,%,,Not Active,50,,patch clamp,Inhibition of human GABAB R1/R2 receptor expressed in HEK293 cells co-expressing human Cav2.2 alpha1B/alpha2delta1/beta3 channel assessed as inhibition of depolarization-activated Ba2+ current at 50 uM followed by compound washout by whole cell patch clamp technique relative to control,HEK293,Homo sapiens,ChEMBL
HG-0325916,HG-0325916-0-00,COc1cc(cc2nnn(C)c12)C(CC(=O)O)c3ccc(C)c(CN4CC(C)Oc5ccccc5S4(=O)=O)c3,550.626,Cav1.2,Activity,,,,Not Active,,,other,Blocking of CaV1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327350,HG-0327350-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)C#N)\O,326.347,Cav1.2,Bmax1,83,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327381,HG-0327381-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax1,79,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327353,HG-0327353-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(ccc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax1,49,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,Bmax1,100,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327388,HG-0327388-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2)[N+](=O)[O-])\O,346.335,Cav1.2,Bmax1,100,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327380,HG-0327380-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax1,8,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327354,HG-0327354-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2Cl)\O,335.782,Cav1.2,Bmax1,21,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0062609,HG-0062609-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,346.335,Cav1.2,Bmax1,72,%,=,,,,binding,Bmax1 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0062609,HG-0062609-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,346.335,Cav1.2,Bmax2,28,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327354,HG-0327354-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2Cl)\O,335.782,Cav1.2,Bmax2,79,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327380,HG-0327380-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax2,92,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327350,HG-0327350-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)C#N)\O,326.347,Cav1.2,Bmax2,17,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327353,HG-0327353-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(ccc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax2,51,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327381,HG-0327381-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Bmax2,21,%,=,,,,binding,Bmax2 from dihydropyridine receptor binding assay in guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0009226,HG-0009226-0-03,COCCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-])\O,418.44,Cav1.2,IC50,0.94,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0317373,HG-0317373-0-01,CCO\C(=C\1/[C@H](C(=C(C)N=C1C)C(=O)OC)c2cccc(Cl)c2Cl)\O,384.254,Cav1.2,IC50,1.26,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0327382,HG-0327382-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc3nonc23)\O,371.387,Cav1.2,IC50,2.2,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0310311,HG-0310311-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-])\O,388.414,Cav1.2,IC50,3,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit,CHO,Cricetulus griseus,ChEMBL
HG-0306164,HG-0306164-0-01,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCCN(C)Cc2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,479.525,Cav1.2,IC50,3.93,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0242918,HG-0242918-0-01,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2ccccc2\C=C\C(=O)OC(C)(C)C)\O,455.543,Cav1.2,IC50,4.92,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0009260,HG-0009260-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC,484.628,Cav1.2,IC50,17,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,IC50,22,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0054606,HG-0054606-0-00,CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2O,288.424,Cav1.2,IC50,34,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0054606,HG-0054606-0-00,CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2O,288.424,Cav1.2,IC50,38.4,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,IC50,50,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit,CHO,Cricetulus griseus,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,IC50,55,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0327439,HG-0327439-0-00,CC(C)O\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCCCCCCCCCC[N+](C)(C)C)c2cccc3nonc23)\O,555.729,Cav1.2,IC50,70,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit,CHO,Cricetulus griseus,ChEMBL
HG-0327434,HG-0327434-0-00,CCO\C(=C\1/C(C(=C(C)N=C1C)C#N)c2cnccc2c3ccc4ccccc4c3)\O,409.48,Cav1.2,IC50,100,nM,=,,,,binding,Binding affinity for DHP (Dihydropyridine) site of L-type calcium channel of calf heart in the resting state,,Bos taurus,ChEMBL
HG-0009226,HG-0009226-0-00,COCCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC(C)C)c2cccc(c2)[N+](=O)[O-])\O,418.44,Cav1.2,IC50,110,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0327446,HG-0327446-0-00,CN(CCCc1nc2ccccc2[nH]1)CCC3(CC4CCC3c5ccccc45)OC(=O)C6CC6,457.607,Cav1.2,IC50,140,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0009450,HG-0009450-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,454.602,Cav1.2,IC50,150,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327442,HG-0327442-0-00,CC(C)C1c2ccc(F)cc2C(CC1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C(C)C)OCc5ccccc5,599.778,Cav1.2,IC50,156,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327452,HG-0327452-0-00,CCCCC1CC(CCN(C)CCCc2nc3ccccc3[nH]2)(OC(=O)COC)C(C(C)C)c4ccc(F)cc14,551.735,Cav1.2,IC50,173,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0206889,HG-0206889-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc4cc(F)ccc4C1C(C)C,495.629,Cav1.2,IC50,202,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327442,HG-0327442-0-00,CC(C)C1c2ccc(F)cc2C(CC1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C(C)C)OCc5ccccc5,599.778,Cav1.2,IC50,225,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327431,HG-0327431-0-00,CCO\C(=C\1/C(C(=C(C)N=C1C)C#N)c2cnccc2c3ccccc3)\O,359.421,Cav1.2,IC50,250,nM,=,,,,binding,Binding affinity for DHP (Dihydropyridine) site of L-type calcium channel of calf heart in the resting state,,Bos taurus,ChEMBL
HG-0055782,HG-0055782-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCCN(C)Cc2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,479.525,Cav1.2,IC50,250,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0327372,HG-0327372-0-00,COc1ccc(CCN(C)C2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,494.665,Cav1.2,IC50,260,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327433,HG-0327433-0-00,CCO\C(=C\1/C(C(=C(C)N=C1C)C#N)c2cnccc2c3cccc4ccccc34)\O,409.48,Cav1.2,IC50,270,nM,=,,,,binding,Binding affinity for DHP (Dihydropyridine) site of L-type calcium channel of calf heart in the resting state,,Bos taurus,ChEMBL
HG-0327372,HG-0327372-0-00,COc1ccc(CCN(C)C2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,494.665,Cav1.2,IC50,270,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327450,HG-0327450-0-00,CC(C)C1c2ccc(F)cc2CCC1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C(C)C,493.656,Cav1.2,IC50,347,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0325074,HG-0325074-0-00,COc1cccc2[nH]c(CCCN(C)CCC3(CC4CCCC3c5ccccc45)OC(=O)C(C)C)nc12,503.676,Cav1.2,IC50,387,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327372,HG-0327372-0-00,COc1ccc(CCN(C)C2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,494.665,Cav1.2,IC50,390,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327441,HG-0327441-0-00,COC1CC(CCN(C)CCCc2nc3ccccc3[nH]2)(OC(=O)C(C)C)C(C(C)C)c4ccc(F)cc14,523.682,Cav1.2,IC50,403,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0242927,HG-0242927-0-01,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-])\O,388.414,Cav1.2,IC50,407.15,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0327373,HG-0327373-0-00,COc1ccc(CCNC2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,480.639,Cav1.2,IC50,410,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327445,HG-0327445-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5ccccc45,459.623,Cav1.2,IC50,424,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327443,HG-0327443-0-00,CC(C)C1c2ccc(F)cc2C(O)CC1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C(C)C,509.655,Cav1.2,IC50,426,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327451,HG-0327451-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC(C)(C)c4cc(F)ccc4C1C(C)C,523.682,Cav1.2,IC50,434,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327447,HG-0327447-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCCC1c5ccccc45,473.65,Cav1.2,IC50,437,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327447,HG-0327447-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCCC1c5ccccc45,473.65,Cav1.2,IC50,455,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327373,HG-0327373-0-00,COc1ccc(CCNC2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,480.639,Cav1.2,IC50,460,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327373,HG-0327373-0-00,COc1ccc(CCNC2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,480.639,Cav1.2,IC50,480,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0292576,HG-0292576-0-01,CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,471.673,Cav1.2,IC50,500,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0327372,HG-0327372-0-00,COc1ccc(CCN(C)C2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,494.665,Cav1.2,IC50,500,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327443,HG-0327443-0-00,CC(C)C1c2ccc(F)cc2C(O)CC1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C(C)C,509.655,Cav1.2,IC50,504,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327445,HG-0327445-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5ccccc45,459.623,Cav1.2,IC50,533,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0290587,HG-0290587-0-02,CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,366.54,Cav1.2,IC50,540,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0327373,HG-0327373-0-00,COc1ccc(CCNC2CCCC(C2)C(C#N)(C(C)C)c3ccc(OC)c(OC)c3)cc1OC,480.639,Cav1.2,IC50,540,nM,=,,,,binding,Inhibition of (-)-[3H]- D-888 binding to L-type calcium channels in kitten heart ventricle membranes,,Felis catus,ChEMBL
HG-0327441,HG-0327441-0-00,COC1CC(CCN(C)CCCc2nc3ccccc3[nH]2)(OC(=O)C(C)C)C(C(C)C)c4ccc(F)cc14,523.682,Cav1.2,IC50,588,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0055684,HG-0055684-0-00,Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4,344.837,Cav1.2,IC50,590,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0327447,HG-0327447-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCCC1c5ccccc45,473.65,Cav1.2,IC50,648,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327445,HG-0327445-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5ccccc45,459.623,Cav1.2,IC50,699,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327444,HG-0327444-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5ccccc45,461.596,Cav1.2,IC50,748,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0293336,HG-0293336-0-01,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Br)cc3,420.315,Cav1.2,IC50,1000,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0308526,HG-0308526-0-00,NCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2,295.3,Cav1.2,IC50,1130,nM,=,Original reference for datapoint is pubmed_id: 15338108,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0009227,HG-0009227-0-01,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,370.575,Cav1.2,IC50,1140,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0327423,HG-0327423-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC2CCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-])\O,491.536,Cav1.2,IC50,1200,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0242813,HG-0242813-0-00,CCO\C(=C/1\C(C(=C(C)N=C1COCCN)C(=O)OC)c2ccccc2Cl)\O,408.876,Cav1.2,IC50,1200,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0292576,HG-0292576-0-00,CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,471.673,Cav1.2,IC50,1320,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009227,HG-0009227-0-00,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,370.575,Cav1.2,IC50,1320,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0327486,HG-0327486-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)NC3CCCCC3)c4ccc(Br)cc4,444.34,Cav1.2,IC50,1340,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0290587,HG-0290587-0-00,CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,366.54,Cav1.2,IC50,1400,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009315,HG-0009315-0-02,COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1,458.57,Cav1.2,IC50,1440,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0228416,HG-0228416-0-01,Cc1c(O)cccc1C(=O)NC(CSc2ccccc2)C(O)CN3CC4CCCCC4CC3C(=O)NC(C)(C)C,567.782,Cav1.2,IC50,1540,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0077762,HG-0077762-0-04,CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,318.864,Cav1.2,IC50,1650,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0324221,HG-0324221-0-00,OC(CNCCc1ccc(NS(=O)(=O)c2ccc(cc2)c3nc(cs3)c4ccc(cc4)C(F)(F)F)cc1)c5cccnc5,624.696,Cav1.2,IC50,1700,nM,=,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0307718,HG-0307718-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3ccccc3OC(F)(F)F)NC(=O)OC(C)(C)C,549.582,Cav1.2,IC50,1725,nM,=,,,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0327418,HG-0327418-0-00,COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC,511.512,Cav1.2,IC50,1750,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit,CHO,Cricetulus griseus,ChEMBL
HG-0308076,HG-0308076-0-00,CNC1(CCCCC1=O)c2ccccc2Cl,237.725,Cav1.2,IC50,1800,nM,=,Hill slope of 2.3. Original reference for datapoint is pubmed_id: 18671719,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in human atrial myocytes,Cardiac Muscle Cell,Homo sapiens,ChEMBL
HG-0327479,HG-0327479-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)NCCc3ccccc3)c4ccc(Br)cc4,466.345,Cav1.2,IC50,1880,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0310795,HG-0310795-0-01,Oc1nc2ccccc2n1C3CCN(CCCOc4ccc(F)cc4)CC3,369.433,Cav1.2,IC50,1920,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0327488,HG-0327488-0-00,OCCC1(CC(=NN1C(=O)Nc2ccc(F)cc2)c3ccccc3)c4ccccc4,403.449,Cav1.2,IC50,1940,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309337,HG-0309337-0-00,CC(O)C1C2C(C)C(=C(N2C1=O)C(=O)O)SC3CNC(CNS(=O)(=O)N)C3,420.504,Cav1.2,IC50,1995.26,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0310205,HG-0310205-0-00,FC(F)(F)c1ccccc1c2noc(n2)C3CCN(CC3)C(=O)NC4CC4c5ccccc5,456.46,Cav1.2,IC50,2000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327500,HG-0327500-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)Nc3ccccn3)c4ccc(Br)cc4,439.28,Cav1.2,IC50,2180,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327477,HG-0327477-0-00,CN(C)CCC1(CC(=NN1C(=O)Nc2ccc(F)cc2)c3ccccc3)c4ccc(C)cc4,444.544,Cav1.2,IC50,2200,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0320654,HG-0320654-0-01,NCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2,281.273,Cav1.2,IC50,2288.79,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0318511,HG-0318511-0-01,CN(CCOc1ccc(cc1)[N+](=O)[O-])CCc2ccc(cc2)[N+](=O)[O-],345.35,Cav1.2,IC50,2360,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0327473,HG-0327473-0-00,CC(C)NC(=O)N1N=C(CC1c2ccc(F)cc2)c3ccc(Br)cc3,404.276,Cav1.2,IC50,2360,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0317268,HG-0317268-0-02,COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C,426.481,Cav1.2,IC50,2560,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0327489,HG-0327489-0-00,OCC1(CC(=NN1C(=O)Nc2ccc(F)cc2)c3ccccc3)c4ccc(F)cc4,407.413,Cav1.2,IC50,2650,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327448,HG-0327448-0-00,COC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5ccccc45,403.56,Cav1.2,IC50,2670,nM,=,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0320167,HG-0320167-0-01,Fc1ccc(cc1)C(c2ccccc2)(c3ccccc3F)n4ccnc4,346.373,Cav1.2,IC50,2693.29,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0260084,HG-0260084-0-02,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,327.808,Cav1.2,IC50,2730,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0320616,HG-0320616-0-01,CN(C)c1cccc(c1)C(=O)N2CCN(CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F,441.467,Cav1.2,IC50,2999.67,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0310149,HG-0310149-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5nccc6ccccc56,439.509,Cav1.2,IC50,3000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327494,HG-0327494-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)Nc3ccncc3)c4ccccc4,360.384,Cav1.2,IC50,3090,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327423,HG-0327423-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC2CCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-])\O,491.536,Cav1.2,IC50,3100,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0315337,HG-0315337-0-00,CCCN(C1CCN(Cc2c(OC)cccc2OC)CC1)S(=O)(=O)c3cccc(c3)C(F)(F)F,500.574,Cav1.2,IC50,3200,nM,=,,,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327389,HG-0327389-0-00,NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+](=O)[O-])cc1,331.389,Cav1.2,IC50,3200,nM,=,Original reference for datapoint is pubmed_id: 16086157,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0307718,HG-0307718-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3ccccc3OC(F)(F)F)NC(=O)OC(C)(C)C,549.582,Cav1.2,IC50,3500,nM,=,,,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0327371,HG-0327371-0-00,CCOc1ccc(Oc2ccc(OCc3cc(F)ccc3F)cc2)c(N)c1,371.377,Cav1.2,IC50,3600,nM,=,Original reference for datapoint is pubmed_id: 16086157,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0327457,HG-0327457-0-00,CN1CCN(CCC2(CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccccc4)c5ccc(C)cc5)CC1,499.622,Cav1.2,IC50,3600,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0293540,HG-0293540-0-02,COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c3cc(Cl)c(N)cc3OC,465.945,Cav1.2,IC50,3610,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0318481,HG-0318481-0-01,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,344.488,Cav1.2,IC50,3619.76,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0327438,HG-0327438-0-00,FC1(F)CCN(CC1Oc2ccc3ccccc3n2)C(=O)c4ccccc4n5nccn5,435.426,Cav1.2,IC50,3800,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327502,HG-0327502-0-00,CC1CC(=NN1C(=O)Nc2ccc(F)cc2)c3ccccc3,297.327,Cav1.2,IC50,3900,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0242813,HG-0242813-0-00,CCO\C(=C/1\C(C(=C(C)N=C1COCCN)C(=O)OC)c2ccccc2Cl)\O,408.876,Cav1.2,IC50,4200,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0215115,HG-0215115-0-01,CCOC(=O)Nc1ccc2CCc3ccccc3N(CCCN(C)C)c2c1,367.485,Cav1.2,IC50,4210,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0260084,HG-0260084-0-05,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,327.808,Cav1.2,IC50,4330,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0292473,HG-0292473-0-03,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,326.823,Cav1.2,IC50,4350,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0330433,HG-0330433-0-00,CC(NC(=O)c1c(CN2CCC(CC2)N3CCCCC3)c(nc4ccccc14)c5cccc(c5)C(F)(F)F)c6ccccc6,600.716,Cav1.2,IC50,4500,nM,=,,,,patch clamp,Inhibition of Cav1.2 (unknown origin) by patchXpress electrophysiology assay,,Homo sapiens,ChEMBL
HG-0330725,HG-0330725-0-00,CC1CCC(CN1C(=O)C2CC2)c3nc(c4ccc(cc4F)C(=O)Nc5cc(ccn5)C(F)(F)F)c6c(N)nccn36,581.564,Cav1.2,IC50,4500,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327449,HG-0327449-0-00,CC(C)C(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CC4CCC1c5nccnc45,461.599,Cav1.2,IC50,4600,nM,>,,,,patch clamp,Inhibition of recombinant Cav1.2 channel (unknown origin) expressed in HEK293 cells assessed as effect on calcium flux incubated for 3 mins by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0009404,HG-0009404-0-03,Oc1nc2ccccc2n1C3=CCN(CCCC(=O)c4ccc(F)cc4)CC3,379.427,Cav1.2,IC50,4650,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0327462,HG-0327462-0-00,COc1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(Br)cc3)c4cccnc4,495.368,Cav1.2,IC50,4800,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0242963,HG-0242963-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC2CCCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-])\O,505.562,Cav1.2,IC50,4900,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0307993,HG-0307993-0-00,CC1CN(CC(Cc2ccccc2)C(=O)NCC(=O)O)CCC1(C)c3cccc(O)c3,424.533,Cav1.2,IC50,5011.87,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0313240,HG-0313240-0-00,CC#CC(C1OC(=O)NC1=O)c2ccc(Oc3ccc(cc3OC(F)F)C(F)(F)F)cc2,455.332,Cav1.2,IC50,5100,nM,=,,,,other,Inhibition of Cav1.2 calcium channel,,Homo sapiens,ChEMBL
HG-0318724,HG-0318724-0-00,COCCO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC\C=C\c2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,492.52,Cav1.2,IC50,5300,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0292482,HG-0292482-0-00,CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2,309.326,Cav1.2,IC50,5400,nM,=,Original reference for datapoint is pubmed_id: 15338108,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0327456,HG-0327456-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccncc4)cc1,378.375,Cav1.2,IC50,5400,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0316625,HG-0316625-0-00,COC(=O)C(CCC(=O)N(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(Br)cc3,514.455,Cav1.2,IC50,5420,nM,=,,,,patch clamp,Inhibition of L-type calcium channel subunit-1C (unknown origin) expressed in HEK293 cells by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0242833,HG-0242833-0-01,CNCCC(Oc1ccccc1C)c2ccccc2,255.355,Cav1.2,IC50,5624.33,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0327496,HG-0327496-0-00,Cc1nnc2sc(C(=O)NCc3ccc(cc3)S(=O)(=O)C(F)F)c(N)c2c1C,426.461,Cav1.2,IC50,5700,nM,=,,,,binding,Binding affinity to human Cav1.2 by radio-ligand binding assay,,Homo sapiens,ChEMBL
HG-0327499,HG-0327499-0-00,COc1ccc(cc1)C2=NN(C(=O)Nc3ccc(Cl)cc3)C(CCO)(C2)c4cccnc4,450.917,Cav1.2,IC50,5700,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0316626,HG-0316626-0-00,COC(=O)C(CCC(=O)N1CCN(CC1)c2ccccc2OC)(C(C)C)c3ccc(Br)cc3,517.455,Cav1.2,IC50,5900,nM,=,,,,patch clamp,Inhibition of L-type calcium channel subunit-1C (unknown origin) expressed in HEK293 cells by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0327463,HG-0327463-0-00,Cc1ccc(cc1)C2(CCN3CCOCC3)CC(=NN2C(=O)Nc4ccc(F)cc4)c5ccccc5,486.58,Cav1.2,IC50,5900,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327501,HG-0327501-0-00,COCCOc1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccccc4,477.527,Cav1.2,IC50,6300,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0009404,HG-0009404-0-02,Oc1nc2ccccc2n1C3=CCN(CCCC(=O)c4ccc(F)cc4)CC3,379.427,Cav1.2,IC50,6300,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0310029,HG-0310029-0-00,O=C(OC1CN2CCC1CC2)N3CCc4ccccc4C3c5ccccc5,362.465,Cav1.2,IC50,6309.57,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0327456,HG-0327456-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccncc4)cc1,378.375,Cav1.2,IC50,6400,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0310131,HG-0310131-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ccc6ccccc6n5,439.509,Cav1.2,IC50,6800,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327456,HG-0327456-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccncc4)cc1,378.375,Cav1.2,IC50,7800,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330629,HG-0330629-0-00,CC(C)C1(CCC(C)(C1)c2nc(c3ccc(cc3)C(=O)Nc4cc(ccn4)C(F)(F)F)c5c(N)nccn25)C(=O)O,566.574,Cav1.2,IC50,8000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0313048,HG-0313048-0-00,Nc1nc(CC(=O)Nc2ccc(CC3CCC(N3)C(O)c4ccccc4)cc2)cs1,422.543,Cav1.2,IC50,8200,nM,=,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0313048,HG-0313048-0-00,Nc1nc(CC(=O)Nc2ccc(CC3CCC(N3)C(O)c4ccccc4)cc2)cs1,422.543,Cav1.2,IC50,8200,nM,=,,,,binding,Displacement of [3H]-diltiazem from human CaV1.2,,Homo sapiens,ChEMBL
HG-0322905,HG-0322905-0-01,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5,342.472,Cav1.2,IC50,8541.71,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0327467,HG-0327467-0-00,Cc1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccncc4,418.463,Cav1.2,IC50,8600,nM,=,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0055782,HG-0055782-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCCN(C)Cc2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,479.525,Cav1.2,IC50,9600,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0327462,HG-0327462-0-00,COc1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(Br)cc3)c4cccnc4,495.368,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0316036,HG-0316036-0-00,CC1CCCN(C1C)C(=O)c2nc(Nc3ccc(Cl)cc3F)sc2C,381.895,Cav1.2,IC50,10000,nM,=,,,,patch clamp,Inhibition of CaV1.2 channel (unknown origin) by patch express-based electrophysiology assay,,Homo sapiens,ChEMBL
HG-0327508,HG-0327508-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccccc4)cc1,377.387,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0326350,HG-0326350-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)Nc3cccc(F)c3)c4ccc(Br)cc4,456.283,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327471,HG-0327471-0-00,CS(=O)(=O)c1ccc(cc1)C2CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccncc4,438.475,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0316035,HG-0316035-0-00,CC1CCCN(C1C)C(=O)c2csc(Nc3ccc(C)cc3)n2,329.46,Cav1.2,IC50,10000,nM,=,,,,patch clamp,Inhibition of CaV1.2 channel (unknown origin) by patch express-based electrophysiology assay,,Homo sapiens,ChEMBL
HG-0327485,HG-0327485-0-00,COCC1(CC(=NN1C(=O)Nc2ccc(F)cc2)c3ccccc3)c4ccc(C)cc4,417.475,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327458,HG-0327458-0-00,[O-][n+]1ccc(cc1)C2=NN(C(C2)c3ccc(F)cc3)C(=O)Nc4ccc(F)cc4,394.374,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327480,HG-0327480-0-00,COc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccc(Br)cc4)cc1,468.318,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327461,HG-0327461-0-00,Fc1ccc(NC(=S)N2N=C(CC2c3ccc(F)cc3)c4ccc(Br)cc4)cc1,472.348,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0314666,HG-0314666-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccccc5)c6cc(O)ncn6,520.582,Cav1.2,IC50,10000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0327482,HG-0327482-0-00,CS(=O)(=O)c1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccccc4,481.539,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327464,HG-0327464-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)Nc3ccccc3F)c4ccc(Br)cc4,456.283,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327498,HG-0327498-0-00,CS(=O)(=O)c1ccc(cc1)C2CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccccc4,437.487,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327420,HG-0327420-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccccc5)c6cc(O)ccn6,519.594,Cav1.2,IC50,10000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0327421,HG-0327421-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccccc5)c6ccnc(O)n6,520.582,Cav1.2,IC50,10000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0327483,HG-0327483-0-00,CN(C)CCOc1ccc(cc1)C2(CCO)CC(=NN2C(=O)Nc3ccc(F)cc3)c4ccccc4,490.569,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327459,HG-0327459-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccc(Br)cc4)cc1,456.283,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327491,HG-0327491-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)c3ccccc3)c4ccc(Br)cc4,423.278,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0326026,HG-0326026-0-00,Fc1ccc(cc1)C2CC(=NN2C(=O)Nc3ccccc3)c4ccc(Br)cc4,438.292,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327469,HG-0327469-0-00,CCc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccc(Br)cc4)cc1,466.345,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327422,HG-0327422-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccccc5)c6ccc(O)nn6,520.582,Cav1.2,IC50,10000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0316134,HG-0316134-0-00,CNc1nc(C)nc(n1)N2CCC(CC2)C(=O)NCc3ccc(Br)cc3OC(F)(F)F,503.316,Cav1.2,IC50,10000,nM,>,,,,other,Inhibition of CaV1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327468,HG-0327468-0-00,CC1=NN(C(C1)c2ccc(F)cc2)C(=O)Nc3ccc(F)cc3,315.317,Cav1.2,IC50,10000,nM,>,,,,patch clamp,Inhibition of recombinant T-type calcium channel Cav1.2 (unknown origin) expressed in HEK293 cells assessed as inhibition of Kcl-induced calcium influx preincubated for 3 mins prior CaCl2 addition by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0322504,HG-0322504-0-01,Fc1ccc(cc1)C(=O)N2CCN(CCCc3ccccc3)CC2,326.408,Cav1.2,IC50,10190,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0318479,HG-0318479-0-01,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,290.44,Cav1.2,IC50,10860.4,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0310483,HG-0310483-0-00,Cn1cc(nn1)C2CCN(CC2)C(=O)NC3CC3c4ccccc4,325.408,Cav1.2,IC50,11000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0310119,HG-0310119-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4oc5ccccc5n4,361.437,Cav1.2,IC50,12000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0318724,HG-0318724-0-00,COCCO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC\C=C\c2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,492.52,Cav1.2,IC50,12700,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0326079,HG-0326079-0-00,Cc1cc(cc(C)c1OCCCC(=O)O)c2cc(OC(F)(F)F)ccc2Cl,402.792,Cav1.2,IC50,12840,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330463,HG-0330463-0-00,CC1(CCCC(C)(C1)c2nc(c3ccc(cc3)C(=O)Nc4cc(ccn4)C(F)(F)F)c5c(N)nccn25)C(=O)O,552.548,Cav1.2,IC50,13000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0325485,HG-0325485-0-00,OC(C1CCC(Cc2ccc(NC(=O)CN3C=Nc4ccccc4C3=O)cc2)N1)c5ccccc5,468.547,Cav1.2,IC50,13000,nM,=,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0009223,HG-0009223-0-03,Oc1nc2ccccc2n1CCCN3CCC(CC3)n4c(O)nc5cc(Cl)ccc45,425.911,Cav1.2,IC50,13240,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0242963,HG-0242963-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC2CCCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-])\O,505.562,Cav1.2,IC50,13800,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0309468,HG-0309468-0-00,CC(C)(C)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C(F)C1,389.335,Cav1.2,IC50,14900,nM,=,,,,patch clamp,Inhibition of human L-type Cav1.2 expressed in HEK293 cells at -100mV holding potential by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0330501,HG-0330501-0-00,CC1(CCC(C)(CC1)c2nc(c3ccc(cc3)C(=O)Nc4cc(ccn4)C(F)(F)F)c5c(N)nccn25)C(=O)O,552.548,Cav1.2,IC50,15000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330729,HG-0330729-0-00,CCOc1cc(ccc1c2nc(n3ccnc(N)c23)C45CCC(CC4)(CC5)C(=O)O)C(=O)Nc6cc(ccn6)C(F)(F)F,594.584,Cav1.2,IC50,15000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0310099,HG-0310099-0-00,FC(F)(F)c1ccc(NC(=O)N2CCC(CC2)c3onc(n3)c4ccccn4)cc1,417.384,Cav1.2,IC50,15000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0326001,HG-0326001-0-00,OC(=O)CCc1oc2ccc(cc2c1)c3cc(OC(F)(F)F)ccc3F,368.279,Cav1.2,IC50,15090,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0308669,HG-0308669-0-00,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3,405.435,Cav1.2,IC50,15848.9,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0306650,HG-0306650-0-00,COc1ccc(cc1)S(=O)(=O)Nc2c(C)cc(C)cc2C,305.392,Cav1.2,IC50,15848.9,nM,>,,,,other,Antagonist activity at human CaV1.2 channel expressed in HEK293 cells by FLIPR/summary (Abse5) assay,HEK293,Homo sapiens,ChEMBL
HG-0242790,HG-0242790-0-00,CCCc1nc(C)c2c(O)nc(nn12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4,488.603,Cav1.2,IC50,15848.9,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0318480,HG-0318480-0-01,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,302.451,Cav1.2,IC50,17914.3,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0310370,HG-0310370-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5cccnc5,389.45,Cav1.2,IC50,19000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0330071,HG-0330071-0-00,CC1(CCC(C)(C1)c2nc(c3ccc(cc3)C(=O)Nc4cc(ccn4)C(F)(F)F)c5c(N)nccn25)C(=O)O,538.521,Cav1.2,IC50,19000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0278808,HG-0278808-0-00,COc1ccc2nccc(C(O)C3CC4CCN3CC4C=C)c2c1,324.417,Cav1.2,IC50,19820,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0314584,HG-0314584-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccc(cc5C)C(=O)O)c6cnccn6,562.618,Cav1.2,IC50,20000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0327419,HG-0327419-0-00,CC1(CNC2(CCCC2)C(=O)N1CC(=O)Nc3cnc4CC5(Cc4c3)C(=O)Nc6ncccc56)c7cc(F)cc(F)c7,572.605,Cav1.2,IC50,20000,nM,>,,,,patch clamp,Inhibition of CaV1.2 ion channel by voltage clamp assay,,Homo sapiens,ChEMBL
HG-0327385,HG-0327385-0-00,O=C(NC1CC1c2ccccc2)N3CCC4(CC3)CCc5ncccc5O4,363.453,Cav1.2,IC50,20000,nM,=,,,,other,Activity at Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0313178,HG-0313178-0-00,Cc1cccc(Nc2ccc(cc2)c3ccc(nc3)N4CCNCC4)n1,345.441,Cav1.2,IC50,20000,nM,=,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0314532,HG-0314532-0-00,Cc1cccnc1CN2CCC3(CC2)N(C(=O)N(C3=O)c4ccc(cc4)c5ccc(cc5C)C(=O)O)c6ccncn6,562.618,Cav1.2,IC50,20000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0292677,HG-0292677-0-02,Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2,395.427,Cav1.2,IC50,20350,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0326136,HG-0326136-0-00,OC(=O)CC1CCC2(CC1)CCN(CC2)c3cc(OC(F)(F)F)ccc3Cl,405.839,Cav1.2,IC50,21000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0207226,HG-0207226-0-00,CC(C)NCC(O)COc1cccc2ccccc12,259.343,Cav1.2,IC50,21000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0326057,HG-0326057-0-00,Cc1nccn1c2ccc(cc2)c3cn(CC(=O)Nc4cccc(Cl)c4Cl)nn3,427.287,Cav1.2,IC50,21000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0194800,HG-0194800-0-01,CCCN(CCC)CC(O)COc1ccccc1C(=O)Nc2ccccc2,370.485,Cav1.2,IC50,21120,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0306248,HG-0306248-0-00,CCC(CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,354.449,Cav1.2,IC50,23400,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009450,HG-0009450-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,454.602,Cav1.2,IC50,23500,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Chinese hamster ovary cells heterologically expressing alpha-1C subunit,CHO,Cricetulus griseus,ChEMBL
HG-0009450,HG-0009450-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,454.602,Cav1.2,IC50,24000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0055782,HG-0055782-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCCN(C)Cc2ccccc2)c3cccc(c3)[N+](=O)[O-])\O,479.525,Cav1.2,IC50,24100,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0242965,HG-0242965-0-00,CC(C)N(CCC(c1ccccc1)c2cc(C)ccc2O)C(C)C,325.488,Cav1.2,IC50,25118.9,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242816,HG-0242816-0-00,CNCCC(Oc1cccc2ccccc12)c3cccs3,297.415,Cav1.2,IC50,25118.9,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0313361,HG-0313361-0-00,CC#CC(CC(=O)O)c1ccc(Oc2ccc(cc2OC(F)F)C(F)(F)F)cc1F,432.313,Cav1.2,IC50,25600,nM,=,,,,other,Inhibition of Cav1.2 calcium channel,,Homo sapiens,ChEMBL
HG-0327387,HG-0327387-0-00,Cn1nccc1Nc2ccc3OC4(CCN(CC4)C(=O)NC5CC5c6ccccc6)CC(=O)c3c2,471.551,Cav1.2,IC50,26000,nM,=,,,,other,Activity at Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327507,HG-0327507-0-00,COC1CC(C1)Oc2cc(F)c(F)c(n2)c3ccc4OC(CCC(=O)O)CCc4c3,419.419,Cav1.2,IC50,28000,nM,=,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327386,HG-0327386-0-00,Cn1nccc1c2ccc3OC4(CCN(CC4)C(=O)NC5CC5c6ccccc6)CC(=O)c3c2,456.536,Cav1.2,IC50,28000,nM,=,,,,other,Activity at Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0242800,HG-0242800-0-03,COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2,277.402,Cav1.2,IC50,28590,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0313350,HG-0313350-0-00,CC#CC(CC(=O)O)c1ccc(Oc2ccc(cc2OC(F)F)C(F)(F)F)cc1,414.323,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 calcium channel,,Homo sapiens,ChEMBL
HG-0228566,HG-0228566-0-02,OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F,306.271,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0310463,HG-0310463-0-00,Cc1noc(n1)C2CCN(CC2)C(=O)NC3CC3c4ccccc4,326.393,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0306630,HG-0306630-0-02,OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O,331.342,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0208071,HG-0208071-0-02,NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl,330.744,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0316567,HG-0316567-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCc4ccnn34)cc2)N1)c5cccnc5,417.503,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human CaV1.2,,Homo sapiens,ChEMBL
HG-0310182,HG-0310182-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)n4cccn4,310.393,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0310075,HG-0310075-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ncccn5,390.438,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0325490,HG-0325490-0-00,CC(N1N=CC=CC1=O)C(=O)Nc2ccc(CC3CCC(N3)C(O)c4ccccc4)cc2,432.515,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0310390,HG-0310390-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)n4ccnn4,311.382,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0309426,HG-0309426-0-00,COCCCn1cc(CN(C2CC2)C(=O)C3CNCCC3C4=CC(=O)N(C)C=C4)c5ccccc15,476.61,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of human Cav1.2,,Homo sapiens,ChEMBL
HG-0308738,HG-0308738-0-00,CC1CN(CCN1c2ncc(OCc3ccc(CS(=O)(=O)C)cc3F)cn2)c4onc(n4)C(F)(F)F,530.496,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of CaV1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0308162,HG-0308162-0-01,COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2,373.876,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0317289,HG-0317289-0-02,CCN(CC)CCCNc1ccnc2cc(Cl)ccc12,291.819,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0325354,HG-0325354-0-00,NC1CC(COC1c2cc(F)ccc2F)N3Cc4cn(nc4C3)S(=O)(=O)C5CC5,424.465,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0326038,HG-0326038-0-00,Cc1cn(cn1)c2ccc(cc2F)c3cn(CC(=O)Nc4cccc(Cl)c4Cl)nn3,445.277,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0325486,HG-0325486-0-00,OC(C1CCC(Cc2ccc(NC(=O)CN3N=CC=CC3=O)cc2)N1)c4ccccc4,418.488,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0325489,HG-0325489-0-00,OC(C1CCC(Cc2ccc(NC(=O)CN3C=CC=CC3=O)cc2)N1)c4ccccc4,417.5,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0325137,HG-0325137-0-00,Cc1nnc2CCc3cc(ccc3n12)c4cncc(c4)C(C)(O)C(F)(F)F,374.36,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0325487,HG-0325487-0-00,OC(C1CCC(Cc2ccc(NC(=O)CN3C=NC=CC3=O)cc2)N1)c4ccccc4,418.488,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0316565,HG-0316565-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCc4scnc34)cc2)N1)c5cccnc5,434.554,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human CaV1.2,,Homo sapiens,ChEMBL
HG-0330084,HG-0330084-0-00,CN1N=C(C=CC1=O)N2CCC3(CCN(CC(O)c4ccc5C(=O)OCc5c4C)CC3)C2=O,452.503,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0316566,HG-0316566-0-00,Cc1nc2C(CCc2s1)C(=O)Nc3ccc(CC4CCC(N4)C(O)c5cccnc5)cc3,448.58,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human CaV1.2,,Homo sapiens,ChEMBL
HG-0327383,HG-0327383-0-00,CS(=O)(=O)c1ccc2OC3(CCCN(CC3)C(=O)NC4CC4c5ccccc5)CCc2c1,454.582,Cav1.2,IC50,30000,nM,>,,,,other,Activity at Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0309978,HG-0309978-0-00,Cn1cnnc1C2CCN(CC2)C(=O)NC3CC3c4ccccc4,325.408,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0310321,HG-0310321-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5cnccn5,390.438,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0009343,HG-0009343-0-02,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,239.741,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0316567,HG-0316567-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCc4ccnn34)cc2)N1)c5cccnc5,417.503,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0242930,HG-0242930-0-03,CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2,441.565,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0310472,HG-0310472-0-00,O=C(NC1CCc2ccccc2CC1)N3CCC(CC3)c4onc(n4)c5ccccn5,417.503,Cav1.2,IC50,30000,nM,=,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0306635,HG-0306635-0-01,COc1c(N2CC3CCCNC3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,401.431,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0317266,HG-0317266-0-01,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,396.506,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0242916,HG-0242916-0-02,Cc1cccc(CCN2CCC(CC2)C(=O)c3ccc(NS(=O)(=O)C)cc3)n1,401.522,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0325491,HG-0325491-0-00,CC(N1N=CC=CC1=O)C(=O)Nc2ccc(CC3CCC(N3)C(O)c4cccnc4)cc2,433.503,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0313177,HG-0313177-0-00,CN1CCN(CC1)c2ccc(cc2C(F)(F)F)c3ccc4CNCCc4c3,375.431,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2,,Homo sapiens,ChEMBL
HG-0207305,HG-0207305-0-03,CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1,272.364,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0310515,HG-0310515-0-00,COc1ccc(CCN2C(CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1,419.495,Cav1.2,IC50,30000,nM,>,,,,patch clamp,Inhibition of Cav1.2 expressed in CHO cells by patch-clamp technique,CHO,Homo sapiens,ChEMBL
HG-0009201,HG-0009201-0-02,NC(=N)Nc1nc(CSCCC(=N)NS(=O)(=O)N)cs1,337.445,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0325492,HG-0325492-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCC4=CC=CC(=O)N34)cc2)N1)c5ccccc5,443.537,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0009256,HG-0009256-0-02,CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C,339.474,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0310157,HG-0310157-0-00,CS(=O)(=O)c1ccc(cc1)c2noc(n2)C3CCN(CC3)C(=O)NC4CC4c5ccccc5,466.553,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0317251,HG-0317251-0-02,Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O,259.261,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0316279,HG-0316279-0-00,NC1CC(COC1c2cc(F)ccc2F)N3Cc4c[nH]nc4C3,320.337,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0307959,HG-0307959-0-02,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,335.872,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0325972,HG-0325972-0-00,Cc1c(ccc(F)c1C#N)C2CN3CCN(CC3CO2)C(=O)Cc4ccc(cn4)n5cnnn5,462.48,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0326348,HG-0326348-0-00,Cc1nccn1c2ccc(cn2)c3cn(CC(=O)Nc4cccc(Cl)c4Cl)nn3,428.275,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330326,HG-0330326-0-00,Nc1nccn2c(nc(c3ccc(cc3)C(=O)Nc4cc(ccn4)C(F)(F)F)c12)C5CCCC(C5)C(=O)O,524.494,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0310270,HG-0310270-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4ocnn4,312.366,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0317365,HG-0317365-0-01,COc1ccccc1N2CCN(CC2)C(=O)c3ccc4OCC(=O)Nc4c3,367.398,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0310098,HG-0310098-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ccncc5,389.45,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0324271,HG-0324271-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCC4=NC=CC(=O)N34)cc2)N1)c5ccccc5,444.526,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0310148,HG-0310148-0-00,Cc1c(O)noc1C2CCN(CC2)C(=O)NC3CC3c4ccccc4,341.404,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0315166,HG-0315166-0-00,CS(=O)(=O)n1cc2CN(Cc2n1)C3COC(C(N)C3)c4cc(F)ccc4F,398.427,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0310057,HG-0310057-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ccccn5,389.45,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0310057,HG-0310057-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ccccn5,389.45,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0226462,HG-0226462-0-02,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(CC(C)C(=O)C(C)C(O)C1(C)O)OC,747.953,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0315166,HG-0315166-0-00,CS(=O)(=O)n1cc2CN(Cc2n1)C3COC(C(N)C3)c4cc(F)ccc4F,398.427,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0310230,HG-0310230-0-00,OC(=O)c1ccc(cc1)c2noc(n2)C3CCN(CC3)C(=O)NC4CC4c5ccccc5,432.472,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327440,HG-0327440-0-00,Fc1cncc(c1)c2nc3cc(F)c(F)cc3n2C4CC4,289.255,Cav1.2,IC50,30000,nM,>,,,,binding,Inhibition of MK-0499 binding to Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0228944,HG-0228944-0-01,Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C,293.363,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0310057,HG-0310057-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4onc(n4)c5ccccn5,389.45,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0327384,HG-0327384-0-00,O=C(NC1CC1c2ccccc2)N3CCC4(CC3)CC(=O)c5ncccc5O4,377.436,Cav1.2,IC50,30000,nM,>,,,,other,Activity at Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0228378,HG-0228378-0-02,CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,361.367,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0306457,HG-0306457-0-01,COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC,359.459,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 022519,HEK293,Homo sapiens,RIKEN
HG-0330719,HG-0330719-0-00,CC1(O)CCC2C(CCC3C2CCC4(C)C3CCC4C(=O)Cn5cc(cn5)C#N)C1,409.564,Cav1.2,IC50,30000,nM,>,,,,patch clamp,Inhibition of Cav1.2 (unknown origin) by patch clamp assay,,Homo sapiens,ChEMBL
HG-0310195,HG-0310195-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)c4nocn4,312.366,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0313032,HG-0313032-0-00,CC(NC(=O)Cc1ccc(cc1)C2CC2)c3ccc(OCC(F)(F)F)cn3,378.388,Cav1.2,IC50,30000,nM,>,,,,patch clamp,Inhibition of L-type Cav1.2 at -80 mV holding potential by tandard voltage-clamp electrophysiology assay,,Homo sapiens,ChEMBL
HG-0326366,HG-0326366-0-00,OC(=O)CCCOc1ccc(cc1)c2cc(OC(F)(F)F)ccc2Cl,374.739,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0325353,HG-0325353-0-00,CCS(=O)(=O)n1cc2CN(Cc2n1)C3COC(C(N)C3)c4cc(F)ccc4F,412.454,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0316565,HG-0316565-0-00,OC(C1CCC(Cc2ccc(NC(=O)C3CCc4scnc34)cc2)N1)c5cccnc5,434.554,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0325488,HG-0325488-0-00,OC(C1CCC(Cc2ccc(NC(=O)CN3C=CC=NC3=O)cc2)N1)c4ccccc4,418.488,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0324763,HG-0324763-0-00,CCn1cc(cn1)C2(NC(Cc3c2[nH]c4ccccc34)c5nc(c[nH]5)c6ccc(F)cn6)C7=NN(C)C(=O)O7,525.537,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0311105,HG-0311105-0-00,O=C(NC1CCc2ccccc2C1)N3CCC(CC3)c4onc(n4)c5ccccn5,403.477,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0316568,HG-0316568-0-00,Nc1nc2C(CCc2s1)C(=O)Nc3ccc(CC4CCC(N4)C(O)c5ccccc5)cc3,448.58,Cav1.2,IC50,30000,nM,>,,,,binding,Displacement of [3H]-diltiazem from human CaV1.2,,Homo sapiens,ChEMBL
HG-0310337,HG-0310337-0-00,O=C(NC1CC1c2ccccc2)N3CCC(CC3)n4cncn4,311.382,Cav1.2,IC50,30000,nM,>,,,,other,Inhibition of Cav 1.2 channel,,Homo sapiens,ChEMBL
HG-0009346,HG-0009346-0-02,Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl,256.091,Cav1.2,IC50,30000,nM,>,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0317219,HG-0317219-0-02,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,324.417,Cav1.2,IC50,30260,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0228804,HG-0228804-0-01,CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,501.656,Cav1.2,IC50,30729.9,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1402b,HEK293,Homo sapiens,RIKEN
HG-0315739,HG-0315739-0-00,CC(C)(C)NC(=O)NCCN1CCC(CO)(CNC(=O)c2cc(Cl)cc(Cl)c2)CC1,459.41,Cav1.2,IC50,31600,nM,>,,,,patch clamp,Inhibition of calcium channel Cav1.2 (unknown origin) expressed in CHO cells by IONWORKS patch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0316385,HG-0316385-0-00,COc1ccsc1CNCCC2(CCOC3(CCCC3)C2)c4ccccn4,386.551,Cav1.2,IC50,36000,nM,=,,,,patch clamp,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,HEK293,Homo sapiens,ChEMBL
HG-0327355,HG-0327355-0-00,CCC(=O)N(c1ccccc1)C2(CCN(CCC(=O)OC)CC2)C(=O)OC,376.447,Cav1.2,IC50,38900,nM,=,Original reference for datapoint is pubmed_id: 18378969,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in human mesenteric arterial smooth muscle,mesenteric arterial smooth muscle,Homo sapiens,ChEMBL
HG-0226119,HG-0226119-0-03,CN1CCN2C(C1)c3ccccc3Cc4cccnc24,265.353,Cav1.2,IC50,39820,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen) 1393,HEK293,Homo sapiens,RIKEN
HG-0306659,HG-0306659-0-03,CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1,384.576,Cav1.2,IC50,40950,nM,=,,,,other,Compound Inhibition of CACNA1C Calcium Influx Measured in FLIPR Fluorescence Assay (Icagen),HEK293,Homo sapiens,RIKEN
HG-0317319,HG-0317319-0-00,CCCOC(C(=O)OC1CCN(C)CC1)(c2ccccc2)c3ccccc3,367.481,Cav1.2,IC50,41700,nM,=,Original reference for datapoint is pubmed_id: 18092154,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in human atrial myocytes,Cardiac Muscle Cell,Homo sapiens,ChEMBL
HG-0292618,HG-0292618-0-00,COc1ccc(cc1)C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(=O)C,414.518,Cav1.2,IC50,44000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009450,HG-0009450-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,454.602,Cav1.2,IC50,47000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0055608,HG-0055608-0-00,CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O,272.382,Cav1.2,IC50,50000,nM,=,Approximate value,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009450,HG-0009450-0-00,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,454.602,Cav1.2,IC50,50000,nM,=,Approximate value,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0306731,HG-0306731-0-00,COCC(NC(=O)C)C(=O)NCc1ccccc1,250.294,Cav1.2,IC50,50118.7,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0327453,HG-0327453-0-00,CCN(CC)CC(=O)N1CC(Sc2ccccc12)c3ccc(Cl)cc3,374.927,Cav1.2,IC50,52000,nM,=,Original reference for datapoint is pubmed_id: 9300266,,,patch clamp,Inhibition of Cav1.2 calcium current measured using Voltage-clamp 2-electrode in Xenopous Oocyte transfected with human L-type calcium channel,Oocyte,Xenopus,ChEMBL
HG-0308155,HG-0308155-0-00,CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,398.474,Cav1.2,IC50,79432.8,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0314827,HG-0314827-0-00,COc1ccc2N=CC(=O)N(CCN3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1,464.517,Cav1.2,IC50,92000,nM,=,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327351,HG-0327351-0-00,CC(C)c1ccc(C)c(O)c1,150.218,Cav1.2,IC50,98000,nM,=,Original reference for datapoint is pubmed_id: 15033373,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0242816,HG-0242816-0-00,CNCCC(Oc1cccc2ccccc12)c3cccs3,297.415,Cav1.2,IC50,100000,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0278771,HG-0278771-0-00,CCCc1nn(C)c2c(O)nc(nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4,474.576,Cav1.2,IC50,100000,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0316318,HG-0316318-0-00,O=C(Cc1ccc(cc1)n2cnnn2)N3CCN(CCc4ccc5C(=O)OCc5c4)CC3,432.475,Cav1.2,IC50,100000,nM,>,,,,other,Inhibition of Cav1.2 channel (unknown origin),,Homo sapiens,ChEMBL
HG-0316386,HG-0316386-0-00,C(CC1(CCOC2(CCCC2)C1)c3ccccn3)NCc4cccs4,356.525,Cav1.2,IC50,100000,nM,>,,,,patch clamp,Inhibition of human Cav 1.2 ion channel expressed in HEK293 cells by whole-cell patch clamp technique,HEK293,Homo sapiens,ChEMBL
HG-0206889,HG-0206889-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc4cc(F)ccc4C1C(C)C,495.629,Cav1.2,IC50,108000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0228803,HG-0228803-0-00,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,410.484,Cav1.2,IC50,125000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0055757,HG-0055757-0-00,O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3,252.268,Cav1.2,IC50,125000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0208044,HG-0208044-0-00,CC(C)c1ccc(C)cc1O,150.218,Cav1.2,IC50,158000,nM,=,Original reference for datapoint is pubmed_id: 15033373,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0208044,HG-0208044-0-00,CC(C)c1ccc(C)cc1O,150.218,Cav1.2,IC50,158000,nM,=,Original reference for datapoint is pubmed_id: 12010783,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0242930,HG-0242930-0-00,CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2,441.565,Cav1.2,IC50,158489,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0306635,HG-0306635-0-00,COc1c(N2CC3CCCNC3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,401.431,Cav1.2,IC50,168900,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0305493,HG-0305493-0-00,COc1cc(CC=C)ccc1O,164.201,Cav1.2,IC50,187000,nM,=,Original reference for datapoint is pubmed_id: 15033373,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0308155,HG-0308155-0-00,CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,398.474,Cav1.2,IC50,199526,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242870,HG-0242870-0-00,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3,389.449,Cav1.2,IC50,199526,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0307880,HG-0307880-0-00,Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F,529.516,Cav1.2,IC50,199526,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0308355,HG-0308355-0-00,Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,488.006,Cav1.2,IC50,251189,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242790,HG-0242790-0-00,CCCc1nc(C)c2c(O)nc(nn12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4,488.603,Cav1.2,IC50,251189,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0206889,HG-0206889-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc4cc(F)ccc4C1C(C)C,495.629,Cav1.2,IC50,288000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in Xenopus oocyte heterologically expressing alpha-1C subunit,Oocyte,Xenopus,ChEMBL
HG-0207292,HG-0207292-0-00,COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2,427.537,Cav1.2,IC50,311000,nM,=,Original reference for datapoint is pubmed_id: 15277312,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0308661,HG-0308661-0-00,NC(CN1C(=O)C=Nc2ccc(F)cc12)C3CCC(CC3)NCc4ncc5OCC(=O)Nc5n4,467.496,Cav1.2,IC50,333000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0308663,HG-0308663-0-00,COc1cnc2C=CC(=O)N(CC(N)C3CCC(CC3)NCc4ccc5OCC(=O)Nc5n4)c2c1,478.543,Cav1.2,IC50,333000,nM,>,,,,other,Inhibition of potassium channel Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0306635,HG-0306635-0-00,COc1c(N2CC3CCCNC3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,401.431,Cav1.2,IC50,398107,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0228820,HG-0228820-0-00,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c5ccc6OCOc6c5)C1=O,389.404,Cav1.2,IC50,398107,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308355,HG-0308355-0-00,Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,488.006,Cav1.2,IC50,398107,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0242908,HG-0242908-0-00,O=C1N(CC2CCCc3cccc1c23)C4CN5CCC4CC5,296.407,Cav1.2,IC50,398107,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0309380,HG-0309380-0-00,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,426.484,Cav1.2,IC50,398107,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0206868,HG-0206868-0-00,CC(C)CN1C(=O)N(C)C(=O)c2[nH]cnc12,222.244,Cav1.2,IC50,466000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0293583,HG-0293583-0-00,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,284.374,Cav1.2,IC50,471000,nM,=,Original reference for datapoint is pubmed_id: 17895236,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0306682,HG-0306682-0-00,CC(Cc1cc2CCN(CCCO)c2c(c1)C(=O)N)NCCOc3ccccc3OCC(F)(F)F,495.534,Cav1.2,IC50,794328,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0310027,HG-0310027-0-00,OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O,373.362,Cav1.2,IC50,1000000,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0309380,HG-0309380-0-00,CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,426.484,Cav1.2,IC50,1000000,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242930,HG-0242930-0-00,CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2,441.565,Cav1.2,IC50,1023000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0207305,HG-0207305-0-00,CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1,272.364,Cav1.2,IC50,1023000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0009346,HG-0009346-0-00,Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl,256.091,Cav1.2,IC50,1258930,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308620,HG-0308620-0-00,NC(=O)C(C1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5,426.55,Cav1.2,IC50,1584890,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0009346,HG-0009346-0-00,Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl,256.091,Cav1.2,IC50,1584890,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0308180,HG-0308180-0-00,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC2COC3OCCC23)S(=O)(=O)c4ccc(N)cc4,547.664,Cav1.2,IC50,1584890,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0305501,HG-0305501-0-00,FC(F)(F)C(Cl)Br,197.382,Cav1.2,IC50,1800000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0306660,HG-0306660-0-00,CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,581.058,Cav1.2,IC50,1995260,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0327349,HG-0327349-0-00,COc1cc(CCC(=O)C)ccc1O,194.227,Cav1.2,IC50,2000000,nM,=,Estimated IC50. Original reference for datapoint is pubmed_id: 15033373,,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0215522,HG-0215522-0-00,COC(C(Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3,378.421,Cav1.2,IC50,2511890,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0307880,HG-0307880-0-00,Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F,529.516,Cav1.2,IC50,3162280,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0305501,HG-0305501-0-00,FC(F)(F)C(Cl)Br,197.382,Cav1.2,IC50,14500000,nM,=,,,,patch clamp,Inhibition of L-type calcium channel measured using 2-electrode voltage-clamp in human embryonic kidney cells heterologically expressing alpha-1C subunit,HEK293,Homo sapiens,ChEMBL
HG-0306660,HG-0306660-0-00,CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,581.058,Cav1.2,IC50,15848900,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308628,HG-0308628-0-00,NC(CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F,407.314,Cav1.2,IC50,100000000,nM,=,,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0215522,HG-0215522-0-00,COC(C(Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3,378.421,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308111,HG-0308111-0-00,Cc1cc(cc(C)c1Oc2nc(Nc3ccc(cc3)C#N)nc(N)c2Br)C#N,435.277,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0308669,HG-0308669-0-00,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3,405.435,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0308250,HG-0308250-0-00,CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1=O,242.229,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0308994,HG-0308994-0-00,Cc1ccc(cc1C)n2nc(C)c(N=Nc3cccc(c3O)c4cccc(c4)C(=O)O)c2O,442.467,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242930,HG-0242930-0-00,CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2,441.565,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0307842,HG-0307842-0-00,CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)c2oc(C)nn2)C(=O)NCc3ccc(F)cc3)O,444.416,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0310027,HG-0310027-0-00,OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O,373.362,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0307842,HG-0307842-0-00,CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)c2oc(C)nn2)C(=O)NCc3ccc(F)cc3)O,444.416,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0242870,HG-0242870-0-00,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3,389.449,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0306796,HG-0306796-0-00,CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2,263.375,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0278771,HG-0278771-0-00,CCCc1nn(C)c2c(O)nc(nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4,474.576,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0306635,HG-0306635-0-00,COc1c(N2CC3CCCNC3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,401.431,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308111,HG-0308111-0-00,Cc1cc(cc(C)c1Oc2nc(Nc3ccc(cc3)C#N)nc(N)c2Br)C#N,435.277,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0228416,HG-0228416-0-00,Cc1c(O)cccc1C(=O)NC(CSc2ccccc2)C(O)CN3CC4CCCCC4CC3C(=O)NC(C)(C)C,567.782,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0228820,HG-0228820-0-00,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c5ccc6OCOc6c5)C1=O,389.404,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0312003,HG-0312003-0-00,CC(C)c1nnc(C)n1C2CC3CCC(C2)N3CCC(NC(=O)C4CCC(F)(F)CC4)c5ccccc5,513.666,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0228416,HG-0228416-0-00,Cc1c(O)cccc1C(=O)NC(CSc2ccccc2)C(O)CN3CC4CCCCC4CC3C(=O)NC(C)(C)C,567.782,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0242965,HG-0242965-0-00,CC(C)N(CCC(c1ccccc1)c2cc(C)ccc2O)C(C)C,325.488,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0312003,HG-0312003-0-00,CC(C)c1nnc(C)n1C2CC3CCC(C2)N3CCC(NC(=O)C4CCC(F)(F)CC4)c5ccccc5,513.666,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308994,HG-0308994-0-00,Cc1ccc(cc1C)n2nc(C)c(N=Nc3cccc(c3O)c4cccc(c4)C(=O)O)c2O,442.467,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0313726,HG-0313726-0-00,COC1CC(CC(C)C2CC(=O)C(C)\C=C(/C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(/C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC)CCC1OCCO,958.224,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0306796,HG-0306796-0-00,CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2,263.375,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0313726,HG-0313726-0-00,COC1CC(CC(C)C2CC(=O)C(C)\C=C(/C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(/C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC)CCC1OCCO,958.224,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308628,HG-0308628-0-00,NC(CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F,407.314,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (ICaL) in HEK293 cells  (alpha1C/beta2a/alpha2delta1) cells measured using IonWorks Barracuda automated patch clamp platform,HEK293,Homo sapiens,ChEMBL
HG-0308180,HG-0308180-0-00,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC2COC3OCCC23)S(=O)(=O)c4ccc(N)cc4,547.664,Cav1.2,IC50,1000000000,nM,,Inactive,,,patch clamp,Inhibition of long-lasting type calcium current (hICa) in Chinese Hamster Ovary (CHO) cells expressing hCav1.2 measured using IonWorks Quattro automated patch clamp platform,CHO,Cricetulus griseus,ChEMBL
HG-0274964,HG-0274964-0-00,COc1ccccc1O,124.137,Cav1.2,IC50,,,,"inactive at 300 uM, about 10% block at 1mM. Original reference for datapoint is pubmed_id: 15033373",,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0327432,HG-0327432-0-00,CCO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OCC)c2ccccc2c3c4ccccc4cc5ccccc35)\O,505.604,Cav1.2,IC50,,,,Not Active,,,binding,Binding affinity for DHP (Dihydropyridine) site of L-type calcium channel of calf heart in the resting state (inactive),,Bos taurus,ChEMBL
HG-0305424,HG-0305424-0-00,COc1cc(C=O)ccc1O,152.147,Cav1.2,IC50,,,,"inactive at 300 uM, about 10% block at 1mM. Original reference for datapoint is pubmed_id: 15033373",,,patch clamp,Inhibition of Cav1.2 calcium current measured using whole cell patch clamp in dog ventricular myocytes,Ventricular myocyte,Canis lupus familiaris,ChEMBL
HG-0315499,HG-0315499-0-00,COc1cccc(OC)c1CN2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,498.558,Cav1.2,IC50,,,,Not Determined,,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315317,HG-0315317-0-00,CS(=O)(=O)c1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,39,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327472,HG-0327472-0-00,FC1(F)CCN(CC1Oc2nc3ccccc3s2)C(=O)c4ccccc4n5nccn5,441.454,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327475,HG-0327475-0-00,FC1(F)CCN(CC1Oc2ccc3ccccc3n2)C(=O)c4nccc5[nH]ccc45,408.401,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327497,HG-0327497-0-00,FC1(F)CCN(CC1Oc2ccccn2)C(=O)c3ccccc3n4nccn4,385.367,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0315473,HG-0315473-0-00,FC(F)(F)Oc1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327492,HG-0327492-0-00,Fc1cccc(c1)C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,386.367,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0307739,HG-0307739-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3c(F)cccc3F)NC(=O)OC(C)(C)C,501.565,Cav1.2,Inhibition,36,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0325338,HG-0325338-0-00,FC(F)(F)Oc1ccc(cc1)c2ccc3OCCN(Cc4ncccn4)C(=O)c3c2,415.365,Cav1.2,Inhibition,32,%,=,,1,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells co-expressing human CACNB2 and CACNA2D1 assessed as reduction in depolarizing test pulse-induced peak channel current at 1 uM at -80 mV holding potential incubated for 5 mins by automated patch clamp method based Chan test,CHO,Homo sapiens,ChEMBL
HG-0327505,HG-0327505-0-00,Fc1ccc(cc1)C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,386.367,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327414,HG-0327414-0-00,COc1ccccc1c2cc3cc(ccc3n2CC(=O)NC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,477.638,Cav1.2,Inhibition,60,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315497,HG-0315497-0-00,CN(C)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.558,Cav1.2,Inhibition,40,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315483,HG-0315483-0-00,CS(=O)(=O)c1ccc(F)cc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,548.571,Cav1.2,Inhibition,34,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327403,HG-0327403-0-00,COCCn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3cc(C)cc(C)c3,420.587,Cav1.2,Inhibition,70,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327404,HG-0327404-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2Cc4c(C)onc4C)C(C)(C)C(=O)NC(C)(C)C,471.634,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327403,HG-0327403-0-00,COCCn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3cc(C)cc(C)c3,420.587,Cav1.2,Inhibition,81,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0327396,HG-0327396-0-00,CC(O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC3CC3)c4cc(C)cc(C)c4,404.544,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327404,HG-0327404-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2Cc4c(C)onc4C)C(C)(C)C(=O)NC(C)(C)C,471.634,Cav1.2,Inhibition,65,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0327405,HG-0327405-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2Cc4ccc(Cl)cc4)C(C)(C)C(=O)NC(C)(C)C,487.075,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327405,HG-0327405-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2Cc4ccc(Cl)cc4)C(C)(C)C(=O)NC(C)(C)C,487.075,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0315460,HG-0315460-0-00,COC(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,510.526,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327416,HG-0327416-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)C(=O)NC(C)(C)C,470.647,Cav1.2,Inhibition,24,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327395,HG-0327395-0-00,CC(O)Cn1c(cc2cc(ccc12)C(C)(C)CO)c3cc(C)cc(C)c3,351.482,Cav1.2,Inhibition,32,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327506,HG-0327506-0-00,FC(F)(F)c1cccc(OC2CN(CCC2(F)F)C(=O)c3ccccc3n4nccn4)n1,453.365,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327412,HG-0327412-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3cccc(OC(F)(F)F)c3,531.61,Cav1.2,Inhibition,93,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327400,HG-0327400-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3[nH]2)C(C)(C)C(=O)NC(C)(C)C,362.508,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327407,HG-0327407-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3ccc(F)cc3,465.603,Cav1.2,Inhibition,82,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327397,HG-0327397-0-00,CC(O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NCC(F)(F)F)c3cc(C)cc(C)c3,446.505,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0312837,HG-0312837-0-00,NC(=O)c1cc(C(=O)N)n(n1)c2cccc(c2)c3cc(ccc3C(F)(F)F)C(F)(F)F,442.315,Cav1.2,Inhibition,0,%,=,,10,,binding,Inhibition of DLZ binding to Cav1.2 at 10 uM,,Homo sapiens,ChEMBL
HG-0327394,HG-0327394-0-00,COC(=O)C(C)(C)c1ccc2c(c1)cc(c3cc(C)cc(C)c3)n2CC(C)O,379.492,Cav1.2,Inhibition,64,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0307737,HG-0307737-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3c(F)cccc3C(F)(F)F)NC(=O)OC(C)(C)C,551.573,Cav1.2,Inhibition,81,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0315283,HG-0315283-0-00,FC(F)(F)Oc1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,88,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327393,HG-0327393-0-00,CC(O)Cn1c(cc2cc(OC(F)(F)F)ccc12)c3cc(C)cc(C)c3,363.374,Cav1.2,Inhibition,43,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315473,HG-0315473-0-00,FC(F)(F)Oc1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0314534,HG-0314534-0-00,CC(C)c1onc(n1)N2CCN(C(C)C2)c3ncc(OCc4ccncc4C#N)cn3,420.468,Cav1.2,Inhibition,,,,Not Active,,,other,Activity at CaV1.2 channel,,Homo sapiens,ChEMBL
HG-0327484,HG-0327484-0-00,FC(F)(F)c1ccc(OC2CN(CCC2(F)F)C(=O)c3ccccc3n4nccn4)nc1,453.365,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327454,HG-0327454-0-00,Fc1ccccc1C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,386.367,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327487,HG-0327487-0-00,FC1(F)CCN(CC1Oc2ncc3ccccc3n2)C(=O)c4ccccc4n5nccn5,436.414,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327490,HG-0327490-0-00,Cc1ccccc1C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,382.403,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330613,HG-0330613-0-00,NC1(Cc2nc(c[nH]2)c3ccc(OC(F)(F)F)cc3)COC1,313.275,Cav1.2,Inhibition,40,%,<,,10,,other,Inhibition of Cav1.2 (unknown origin) at 10 uM relative to control,,Homo sapiens,ChEMBL
HG-0327476,HG-0327476-0-00,FC1(F)CCN(CC1Oc2cc3ccccc3cn2)C(=O)c4ccccc4n5nccn5,435.426,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0315283,HG-0315283-0-00,FC(F)(F)Oc1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,73,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327429,HG-0327429-0-00,CC(C)Nc1nc2c(C(=O)N(C)C)c(Cl)c(Cl)cc2n1C3CCN(CC3)c4ccc(cc4)C(C)(C)C#N,541.515,Cav1.2,Inhibition,,%,,Not Active,10,,other,Inhibition of human Cav1.2 expressed in HEK293 cells assessed as decrease in calcium immobilization at >10 uM by FLIPR analysis,HEK293,Homo sapiens,ChEMBL
HG-0327493,HG-0327493-0-00,FC(F)(F)c1ccnc(OC2CN(CCC2(F)F)C(=O)c3ccccc3n4nccn4)c1,453.365,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327401,HG-0327401-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2CC(=O)OC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,476.65,Cav1.2,Inhibition,48,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327401,HG-0327401-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2CC(=O)OC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,476.65,Cav1.2,Inhibition,60,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0327398,HG-0327398-0-00,CC(O)Cn1c(cc2cc(ccc12)C(=O)NC(C)(C)C)c3cc(C)cc(C)c3,378.507,Cav1.2,Inhibition,90,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315378,HG-0315378-0-00,CS(=O)(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327392,HG-0327392-0-00,CC(O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)N(C)C)c3cc(C)cc(C)c3,392.534,Cav1.2,Inhibition,52,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327390,HG-0327390-0-00,CCCNC(C)c1c([nH]c2ccc(cc12)C(C)(C)C(=O)N3C4CCC3CC4)c5cc(C)cc(C)c5,471.677,Cav1.2,Inhibition,62,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327417,HG-0327417-0-00,CC(C)(C)NC(=O)C(c1ccccn1)n2ccc3cc(ccc23)C(C)(C)C(=O)NC(C)(C)C,448.6,Cav1.2,Inhibition,64,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315205,HG-0315205-0-00,FC(F)(F)Oc1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,60,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327399,HG-0327399-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2C(=O)OC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,462.624,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0327399,HG-0327399-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2C(=O)OC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,462.624,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0330053,HG-0330053-0-00,CC1CN(CCN1c2ccc(NC3=CC(=CN(C)C3=O)c4ccnc(N5CCn6c7CC(C)(C)Cc7cc6C5=O)c4CO)nc2)C8COC8,664.796,Cav1.2,Inhibition,3.8,%,=,,10,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells at 10 uM incubated for 3 to 5 mins by Qpatch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0315378,HG-0315378-0-00,CS(=O)(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315090,HG-0315090-0-00,COc1cc(Nc2cnc(C#N)c(OC(C)CN(C)C)n2)ncc1c3cnn(C)c3,408.457,Cav1.2,Inhibition,25,%,<,,10,,other,Inhibition of human Cav1.2 at 10 uM,,Homo sapiens,ChEMBL
HG-0327402,HG-0327402-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2CC(=O)NC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,475.665,Cav1.2,Inhibition,78,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327478,HG-0327478-0-00,FC1(F)CCN(CC1Oc2ccc3ccccc3n2)C(=O)c4ccccc4,368.377,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327413,HG-0327413-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3ccc(OC(F)(F)F)cc3,531.61,Cav1.2,Inhibition,85,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315460,HG-0315460-0-00,COC(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,510.526,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0307738,HG-0307738-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3cc(F)ccc3F)NC(=O)OC(C)(C)C,501.565,Cav1.2,Inhibition,24,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0327409,HG-0327409-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3cc(F)cc(c3)C(F)(F)F,533.601,Cav1.2,Inhibition,88,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315483,HG-0315483-0-00,CS(=O)(=O)c1ccc(F)cc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,548.571,Cav1.2,Inhibition,18,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0307722,HG-0307722-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3cccc(F)c3)NC(=O)OC(C)(C)C,483.575,Cav1.2,Inhibition,0,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0327400,HG-0327400-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3[nH]2)C(C)(C)C(=O)NC(C)(C)C,362.508,Cav1.2,Inhibition,,,,Not Determined,,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0315416,HG-0315416-0-00,CS(=O)(=O)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0332346,HG-0332346-0-00,Fc1ccc(CNC(=O)CC2N(C(=Nc3ccccc23)N4CCN(CCN5CCCC5)CC4)c6ccc(cc6)c7ccccc7)cc1,630.797,Cav1.2,Inhibition,,%,,Active,10,,patch clamp,Inhibition of human Cav1.2 (unknown origin) expressed in HEK tsA-201 cells co-transfected with Cavalpha2delta1/Cavbeta1b subunit at 10 uM at holding potential of -110 mV by whole cell patch clamp method relative to control,,Homo sapiens,ChEMBL
HG-0315416,HG-0315416-0-00,CS(=O)(=O)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327398,HG-0327398-0-00,CC(O)Cn1c(cc2cc(ccc12)C(=O)NC(C)(C)C)c3cc(C)cc(C)c3,378.507,Cav1.2,Inhibition,64,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0325949,HG-0325949-0-00,CC1(O)CC(C1)(C(O)c2ccccn2)c3cc(ccn3)C(F)(F)F,338.324,Cav1.2,Inhibition,50,%,<,,10,,binding,Binding affinity to Cav1.2 (unknown origin) at 10 uM,,Homo sapiens,ChEMBL
HG-0327415,HG-0327415-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)C(C)(C)C,427.623,Cav1.2,Inhibition,47,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0316279,HG-0316279-0-00,NC1CC(COC1c2cc(F)ccc2F)N3Cc4c[nH]nc4C3,320.337,Cav1.2,Inhibition,,,,Not Active,,,other,Inhibition of Cav1.2 channel (unknown origin),,Homo sapiens,ChEMBL
HG-0315317,HG-0315317-0-00,CS(=O)(=O)c1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,530.58,Cav1.2,Inhibition,19,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327410,HG-0327410-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3ccc(F)cc3F,483.593,Cav1.2,Inhibition,93,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0325338,HG-0325338-0-00,FC(F)(F)Oc1ccc(cc1)c2ccc3OCCN(Cc4ncccn4)C(=O)c3c2,415.365,Cav1.2,Inhibition,79,%,=,,10,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells co-expressing human CACNB2 and CACNA2D1 assessed as reduction in depolarizing test pulse-induced peak channel current at 10 uM at -80 mV holding potential incubated for 5 mins by automated patch clamp method based Chan test,CHO,Homo sapiens,ChEMBL
HG-0327402,HG-0327402-0-00,Cc1cc(C)cc(c1)c2cc3cc(ccc3n2CC(=O)NC(C)(C)C)C(C)(C)C(=O)NC(C)(C)C,475.665,Cav1.2,Inhibition,33,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay relative to MK-0499,,Homo sapiens,ChEMBL
HG-0325338,HG-0325338-0-00,FC(F)(F)Oc1ccc(cc1)c2ccc3OCCN(Cc4ncccn4)C(=O)c3c2,415.365,Cav1.2,Inhibition,47,%,=,,10,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells co-expressing human CACNB2 and CACNA2D1 assessed as reduction in depolarizing test pulse-induced late channel current at 10 uM at -80 mV holding potential incubated for 5 mins by automated patch clamp method based Chan test,CHO,Homo sapiens,ChEMBL
HG-0327460,HG-0327460-0-00,FC1(F)CCN(CC1Oc2cnc3ccccc3n2)C(=O)c4ccccc4n5nccn5,436.414,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327408,HG-0327408-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F,583.608,Cav1.2,Inhibition,61,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327504,HG-0327504-0-00,COc1cccc(c1)C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,398.403,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0315425,HG-0315425-0-00,NC(=O)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,0,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315425,HG-0315425-0-00,NC(=O)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,0,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0325338,HG-0325338-0-00,FC(F)(F)Oc1ccc(cc1)c2ccc3OCCN(Cc4ncccn4)C(=O)c3c2,415.365,Cav1.2,Inhibition,14,%,=,,1,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells co-expressing human CACNB2 and CACNA2D1 assessed as reduction in depolarizing test pulse-induced late channel current at 1 uM at -80 mV holding potential incubated for 5 mins by automated patch clamp method based Chan test,CHO,Homo sapiens,ChEMBL
HG-0327411,HG-0327411-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3ccccc3OC(F)(F)F,531.61,Cav1.2,Inhibition,79,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327455,HG-0327455-0-00,FC1(F)CCN(CC1Oc2ccc3ccccc3n2)C(=O)c4ccnc5[nH]ccc45,408.401,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0308841,HG-0308841-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3ccccc3F)NC(=O)OC(C)(C)C,483.575,Cav1.2,Inhibition,11,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0306868,HG-0306868-0-00,CC(Oc1ccccc1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C(=O)N(C)CCO,452.503,Cav1.2,Inhibition,,%,,Not Active,2.4,,patch clamp,Inhibition of human CACNA1C channel expressed in CHO cells at 20.4 +/- 2.4 uM by patch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0329992,HG-0329992-0-00,COc1cc(ccc1S(=O)(=O)Nc2ccc3N(C)C(=O)C(=Cc3c2)C)C#N,383.421,Cav1.2,Inhibition,40,%,<,,30,,other,Inhibition of Cav1.2 (unknown origin) at 30 uM,,Homo sapiens,ChEMBL
HG-0327406,HG-0327406-0-00,CC(C)(C)NC(=O)Cn1c(cc2cc(ccc12)C(C)(C)C(=O)NC(C)(C)C)c3ccccc3,447.612,Cav1.2,Inhibition,79,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0327470,HG-0327470-0-00,FC1(F)CCN(CC1Oc2nccc3ccccc23)C(=O)c4ccccc4n5nccn5,435.426,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327474,HG-0327474-0-00,FC1(F)CCN(CC1Oc2ccnc3ccccc23)C(=O)c4ccccc4n5nccn5,435.426,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330581,HG-0330581-0-00,CNC(=O)c1c(oc2ccc(c(F)c12)c3cc(ccc3C)C(=O)NC4(CC4)c5ncccn5)c6ccc(F)cc6,538.544,Cav1.2,Inhibition,,,,Not Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0307691,HG-0307691-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3cccc(c3)C(F)(F)F)NC(=O)OC(C)(C)C,533.582,Cav1.2,Inhibition,19,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0009449,HG-0009449-0-00,CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2,341.444,Cav1.2,Inhibition,72.5,%,=,,10,,patch clamp,Inhibition of Cav1.2 at 10 uM after 5 mins by patch clamp assay,,Homo sapiens,ChEMBL
HG-0327481,HG-0327481-0-00,COc1ccc(F)c(C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3)c1F,434.384,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0315205,HG-0315205-0-00,FC(F)(F)Oc1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,536.487,Cav1.2,Inhibition,78,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0330053,HG-0330053-0-00,CC1CN(CCN1c2ccc(NC3=CC(=CN(C)C3=O)c4ccnc(N5CCn6c7CC(C)(C)Cc7cc6C5=O)c4CO)nc2)C8COC8,664.796,Cav1.2,Inhibition,1.5,%,=,,1,,patch clamp,Inhibition of human Cav1.2 expressed in CHO cells at 1 uM incubated for 3 to 5 mins by Qpatch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0325562,HG-0325562-0-00,CCN1C=C(c2cccc(c2)C(F)(F)F)c3sc(cc3C1=O)C(=N)NC4CCS(=O)(=O)CC4,497.554,Cav1.2,Inhibition,,%,,Not Active,5,,patch clamp,Inhibition of human Cav1.2 channel at <5 uM by electrophysiology,,Homo sapiens,ChEMBL
HG-0332345,HG-0332345-0-00,CN(C)CCCCCN(C)C1=Nc2c(F)cc(F)cc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,609.751,Cav1.2,Inhibition,,%,,Active,10,,patch clamp,Inhibition of human Cav1.2 (unknown origin) expressed in HEK tsA-201 cells co-transfected with Cavalpha2delta1/Cavbeta1b subunit at 10 uM at holding potential of -110 mV by whole cell patch clamp method relative to control,,Homo sapiens,ChEMBL
HG-0327465,HG-0327465-0-00,FC1(F)CCN(CC1Oc2oc3ccccc3n2)C(=O)c4ccccc4n5nccn5,425.388,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327495,HG-0327495-0-00,COc1ccc(F)c(c1)C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,416.393,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327503,HG-0327503-0-00,FC1(F)CCN(CC1Oc2ccc3cccnc3n2)C(=O)c4ccccc4n5nccn5,436.414,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0330033,HG-0330033-0-00,CC(N1C(=O)Oc2cc(ccc12)S(=O)(=O)Nc3ncns3)c4cccc5CCNCc45,457.526,Cav1.2,Inhibition,,,,Not Active,,,other,Activity at Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0315443,HG-0315443-0-00,NC(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327391,HG-0327391-0-00,CCOC(=O)C(C)(C)c1ccc2c(c1)c(C(C)CO)c(c3cc(C)cc(C)c3)n2C(=O)OC(C)(C)C,493.634,Cav1.2,Inhibition,40,%,=,,10,,patch clamp,Blockade of Cav1.2 channel at 10 uM by fluorescent calcium-influx assay,,Homo sapiens,ChEMBL
HG-0315426,HG-0315426-0-00,NC(=O)c1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,17,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0309786,HG-0309786-0-00,OC(CNC1CCCCC1)Cn2c3ccc(Br)cc3c4cc(Br)ccc24,480.236,Cav1.2,Inhibition,,,,Not Active,,,other,Inhibition of human Cav1.2 channel,,Homo sapiens,ChEMBL
HG-0314732,HG-0314732-0-00,CC1CN(CCO1)c2cc(nc(O)n2)N(CCO)Cc3cccc4ccccc34,394.467,Cav1.2,Inhibition,,%,,Not Active,31.6,,patch clamp,Inhibition of human CaV1.2 expressed in CHO cells at 31.6 uM by patch clamp assay,CHO,Homo sapiens,ChEMBL
HG-0315426,HG-0315426-0-00,NC(=O)c1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,11,%,=,,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0308453,HG-0308453-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3ccc(F)cc3)NC(=O)OC(C)(C)C,483.575,Cav1.2,Inhibition,0,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0315496,HG-0315496-0-00,FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4ccccc4,452.49,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315443,HG-0315443-0-00,NC(=O)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.515,Cav1.2,Inhibition,,%,,Not Determined,1,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 1 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0315496,HG-0315496-0-00,FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4ccccc4,452.49,Cav1.2,Inhibition,,%,,Not Determined,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0307736,HG-0307736-0-00,CC(C)N1C(=O)C(CCc2ccccc12)NC(=O)C(Cc3cccc(F)c3C(F)(F)F)NC(=O)OC(C)(C)C,551.573,Cav1.2,Inhibition,87,%,=,,10,,binding,Displacement of [3H]diltiazem from human Cav1.2 expressed in HEK293 cells at 10 uM,HEK293,Homo sapiens,ChEMBL
HG-0315497,HG-0315497-0-00,CN(C)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F,495.558,Cav1.2,Inhibition,63,%,=,,3,,patch clamp,Inhibition of Cav1.2 assessed as inhibition of calcium flux at 3 uM by cell based FLIPR assay,,Homo sapiens,ChEMBL
HG-0327466,HG-0327466-0-00,COc1ccccc1C(=O)N2CCC(F)(F)C(C2)Oc3ccc4ccccc4n3,398.403,Cav1.2,Inhibition,,,,Active,,,other,Inhibition of Cav1.2 (unknown origin),,Homo sapiens,ChEMBL
HG-0327341,HG-0327341-0-00,CSC1=NC2\C(=C(/O)\OCCCCCSc3c2cccc3[N+](=O)[O-])\C(=N1)C,407.507,Cav1.2,Kd,5,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327340,HG-0327340-0-00,COC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])SC,321.352,Cav1.2,Kd,480,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327347,HG-0327347-0-00,COC(=O)C1=C(C)N=C(NC1c2cccc(c2SC)[N+](=O)[O-])SC,367.443,Cav1.2,Kd,30,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0305521,HG-0305521-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,360.361,Cav1.2,Kd,0.26,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0055724,HG-0055724-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)[N+](=O)[O-])c2ccccc2C(F)(F)F)\O,356.297,Cav1.2,Kd,18,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327362,HG-0327362-0-00,CCOC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])OC,319.313,Cav1.2,Kd,105,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327377,HG-0327377-0-00,CO\C(=C/1\C(Sc2ccccc2N=C1C)c3cccc(c3)[N+](=O)[O-])\O,356.396,Cav1.2,Kd,360,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to calcium channels of guinea pig myocardium,,Cavia porcellus,ChEMBL
HG-0327435,HG-0327435-0-00,CCOC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])N(C)C,332.354,Cav1.2,Kd,3400,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327437,HG-0327437-0-00,CCOC(=O)C1=C(C)N=C(NC1c2ccccc2C(F)(F)F)SC,358.379,Cav1.2,Kd,35,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327342,HG-0327342-0-00,CSC1=NC(C2=C(O)OCC2=N1)c3cc(ccc3SC)[N+](=O)[O-],351.401,Cav1.2,Kd,50000,nM,>,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327343,HG-0327343-0-00,CSC1=NC2\C(=C(/O)\OCCCCCSc3ccc(cc23)[N+](=O)[O-])\C(=N1)C,407.507,Cav1.2,Kd,873,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327345,HG-0327345-0-00,CSC1=NC(C2=C(O)OCC2=N1)c3cccc(c3)[N+](=O)[O-],305.309,Cav1.2,Kd,36900,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327352,HG-0327352-0-00,CCOC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])SC,335.378,Cav1.2,Kd,23,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327346,HG-0327346-0-00,COC(=O)C1=C(C)N=C(NC1c2ccccc2SC)SC,322.446,Cav1.2,Kd,1520,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327376,HG-0327376-0-00,COC(=O)C1=C(C)N(CCN(C)C)c2ccccc2SC1c3cccc(c3)[N+](=O)[O-],427.517,Cav1.2,Kd,488,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to calcium channels of guinea pig myocardium,,Cavia porcellus,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,Kd,0.4,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327338,HG-0327338-0-00,CSC1=NC(C2=C(O)OCC2=N1)c3ccccc3SC,306.403,Cav1.2,Kd,45200,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327337,HG-0327337-0-00,CSC1=NC2\C(=C(/O)\OCCCCCSc3ccccc23)\C(=N1)C,362.509,Cav1.2,Kd,18,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327340,HG-0327340-0-00,COC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])SC,321.352,Cav1.2,Kd,120,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327344,HG-0327344-0-00,CCCCSc1ccccc1C2N=C(SC)N=C3COC(=C23)O,348.483,Cav1.2,Kd,50000,nM,>,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327430,HG-0327430-0-00,CSC1=NC(=C(C(N1)c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C,349.405,Cav1.2,Kd,12,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327348,HG-0327348-0-00,COC(=O)C1=C(C)N=C(NC1c2cc(ccc2SC)[N+](=O)[O-])SC,367.443,Cav1.2,Kd,2700,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327436,HG-0327436-0-00,CCC(C)OC(=O)C1=C(C)N=C(NC1c2cccc(c2)[N+](=O)[O-])SC,363.431,Cav1.2,Kd,2.6,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel in guinea pig ventricular myocardium membranes,,Cavia porcellus,ChEMBL
HG-0327339,HG-0327339-0-00,CSC1=NC(C2=C(O)OCC2=N1)c3cccc(c3SC)[N+](=O)[O-],351.401,Cav1.2,Kd,13700,nM,=,,,,binding,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327388,HG-0327388-0-00,CO\C(=C\1/C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2)[N+](=O)[O-])\O,346.335,Cav1.2,Kd1,148,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,Kd1,0.39,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0062609,HG-0062609-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,346.335,Cav1.2,Kd1,0.13,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327381,HG-0327381-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd1,0.23,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327354,HG-0327354-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2Cl)\O,335.782,Cav1.2,Kd1,0.006,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327380,HG-0327380-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd1,1.25,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327350,HG-0327350-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)C#N)\O,326.347,Cav1.2,Kd1,2.15,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327353,HG-0327353-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(ccc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd1,0.95,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0062609,HG-0062609-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,346.335,Cav1.2,Kd2,29.6,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327350,HG-0327350-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)C#N)\O,326.347,Cav1.2,Kd2,152.2,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327381,HG-0327381-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd2,85,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327354,HG-0327354-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2Cl)\O,335.782,Cav1.2,Kd2,1,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327353,HG-0327353-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(ccc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd2,74.4,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0327380,HG-0327380-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccc(cc2Cl)[N+](=O)[O-])\O,380.78,Cav1.2,Kd2,107,nM,=,,,,binding,Dissociation constant for inhibition of [3H]nitrendipine binding to guinea pig myocardial membranes,,Cavia porcellus,ChEMBL
HG-0305521,HG-0305521-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cccc(c2)[N+](=O)[O-])\O,360.361,Cav1.2,Ki,0.25,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.2,Ki,1,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327379,HG-0327379-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2cccc(c2SC)[N+](=O)[O-])\O,420.479,Cav1.2,Ki,1,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327370,HG-0327370-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CCc3cccc4ccccc34)\O,488.575,Cav1.2,Ki,4.11,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327368,HG-0327368-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(CCc3cccc(Br)c3)onc2c4ccccc4)\O,579.482,Cav1.2,Ki,6.89,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327360,HG-0327360-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)onc2c3ccccc3)\O,410.463,Cav1.2,Ki,13.9,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327365,HG-0327365-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CCc3ccc(cc3)c4ccccc4)\O,514.612,Cav1.2,Ki,18.2,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327366,HG-0327366-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CCc3ccc4ccccc4c3)\O,488.575,Cav1.2,Ki,20.2,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327369,HG-0327369-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CCc3ccccc3)\O,438.516,Cav1.2,Ki,22.9,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327358,HG-0327358-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)onc2C)\O,348.394,Cav1.2,Ki,27.1,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327428,HG-0327428-0-00,[2H]C1(C(=C(C)N=C(C)/C/1=C(/O)\OCC)C(=O)OCC)c2c(C)onc2C,349.4,Cav1.2,Ki,28.5,nM,=,,,,binding,Inhibition of [3H]-PN-200110 binding to Calcium channel in guinea pig heart membrane.,,Cavia porcellus,ChEMBL
HG-0327426,HG-0327426-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3ccc(cc23)[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,30,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327367,HG-0327367-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(CCc3cccc(OC)c3)onc2c4ccccc4)\O,530.611,Cav1.2,Ki,39.5,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327357,HG-0327357-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CC)\O,362.42,Cav1.2,Ki,52,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327363,HG-0327363-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(CCc3ccccc3)onc2c4ccccc4)\O,500.585,Cav1.2,Ki,72.9,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327356,HG-0327356-0-00,CCCCCc1onc(c2ccccc2)c1C3C(=C(C)N=C(C)/C/3=C(\O)/OCC)C(=O)OCC,466.569,Cav1.2,Ki,79,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327378,HG-0327378-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2cc(ccc2SC)[N+](=O)[O-])\O,420.479,Cav1.2,Ki,80,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327364,HG-0327364-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CCc3ccccc3c4ccccc4)\O,514.612,Cav1.2,Ki,91.1,nM,=,,,,binding,Displacement of [3H](+)-PN200-110 binding to calcium channels in guinea pig cardiac membranes.,,Cavia porcellus,ChEMBL
HG-0327361,HG-0327361-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2c(C)onc2C)\O,320.34,Cav1.2,Ki,122,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327425,HG-0327425-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3c2cccc3[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,250,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327359,HG-0327359-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(onc2c3ccccc3)C(C)C)\O,438.516,Cav1.2,Ki,417,nM,=,,,,binding,Inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327427,HG-0327427-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3ccccc23)N=C1C)\O,361.455,Cav1.2,Ki,500,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327376,HG-0327376-0-00,COC(=O)C1=C(C)N(CCN(C)C)c2ccccc2SC1c3cccc(c3)[N+](=O)[O-],427.517,Cav1.2,Ki,505,nM,=,,,,binding,Inhibition of [3H]diltiazem binding to calcium channels of guinea pig myocardium,,Cavia porcellus,ChEMBL
HG-0327426,HG-0327426-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3ccc(cc23)[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,650,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327424,HG-0327424-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3cc(ccc23)[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,3000,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327427,HG-0327427-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3ccccc23)N=C1C)\O,361.455,Cav1.2,Ki,5000,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327424,HG-0327424-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3cc(ccc23)[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,5000,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327425,HG-0327425-0-00,CCO\C(=C/1\C2C(C(=O)OCC)C(C)(Sc3c2cccc3[N+](=O)[O-])N=C1C)\O,406.453,Cav1.2,Ki,6000,nM,=,,,,binding,Inhibition of [3H]nitrendipine binding to L-type calcium channel dihydropyridine site of porcine cardiac sarcolemma membrane vesicles,,Sus scrofa,ChEMBL
HG-0327374,HG-0327374-0-00,CC(\N=C(/NC#N)\Nc1ccc(OC(F)F)cc1)C(C)(C)C,310.342,Cav1.2,Peak current,58.2,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0327375,HG-0327375-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(N\C(=N\C#N)\NC(C)C(C)(C)C)ccc2OC(F)F)\O,533.568,Cav1.2,Peak current,9.2,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-6 M",CHO,Homo sapiens,ChEMBL
HG-0327374,HG-0327374-0-00,CC(\N=C(/NC#N)\Nc1ccc(OC(F)F)cc1)C(C)(C)C,310.342,Cav1.2,Peak current,10.8,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0318393,HG-0318393-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2OC(F)F)\O,367.344,Cav1.2,Peak current,7.8,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-8 M",CHO,Homo sapiens,ChEMBL
HG-0327374,HG-0327374-0-00,CC(\N=C(/NC#N)\Nc1ccc(OC(F)F)cc1)C(C)(C)C,310.342,Cav1.2,Peak current,2.4,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-4 M",CHO,Homo sapiens,ChEMBL
HG-0327375,HG-0327375-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(N\C(=N\C#N)\NC(C)C(C)(C)C)ccc2OC(F)F)\O,533.568,Cav1.2,Peak current,60.4,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-6 M",CHO,Homo sapiens,ChEMBL
HG-0318393,HG-0318393-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2OC(F)F)\O,367.344,Cav1.2,Peak current,0.9,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0327375,HG-0327375-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(N\C(=N\C#N)\NC(C)C(C)(C)C)ccc2OC(F)F)\O,533.568,Cav1.2,Peak current,38.2,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0318393,HG-0318393-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2OC(F)F)\O,367.344,Cav1.2,Peak current,9.2,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0318393,HG-0318393-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2OC(F)F)\O,367.344,Cav1.2,Peak current,47.4,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-8 M",CHO,Homo sapiens,ChEMBL
HG-0327375,HG-0327375-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2cc(N\C(=N\C#N)\NC(C)C(C)(C)C)ccc2OC(F)F)\O,533.568,Cav1.2,Peak current,2.5,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -30 mV holding potential, peak Ba2+ current, at 10e-5 M",CHO,Homo sapiens,ChEMBL
HG-0327374,HG-0327374-0-00,CC(\N=C(/NC#N)\Nc1ccc(OC(F)F)cc1)C(C)(C)C,310.342,Cav1.2,Peak current,26.7,%,=,,,,patch clamp,"Inhibition of VGCC alpha-1C-b expressed in CHO cells -80 mV holding potential, peak Ba2+ current, at 10e-4 M",CHO,Homo sapiens,ChEMBL
HG-0327359,HG-0327359-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(onc2c3ccccc3)C(C)C)\O,438.516,Cav1.2,nH,1.55,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327361,HG-0327361-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2c(C)onc2C)\O,320.34,Cav1.2,nH,1.02,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327428,HG-0327428-0-00,[2H]C1(C(=C(C)N=C(C)/C/1=C(/O)\OCC)C(=O)OCC)c2c(C)onc2C,349.4,Cav1.2,nH,1.05,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327356,HG-0327356-0-00,CCCCCc1onc(c2ccccc2)c1C3C(=C(C)N=C(C)/C/3=C(\O)/OCC)C(=O)OCC,466.569,Cav1.2,nH,1.46,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327360,HG-0327360-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)onc2c3ccccc3)\O,410.463,Cav1.2,nH,1.01,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327358,HG-0327358-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)onc2C)\O,348.394,Cav1.2,nH,1.08,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0327357,HG-0327357-0-00,CCO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OCC)c2c(C)noc2CC)\O,362.42,Cav1.2,nH,0.97,,=,,,,binding,Hill coefficient calculated from inhibition of [3H]PN-200110 binding to Calcium channel in guinea pig heart membrane,,Cavia porcellus,ChEMBL
HG-0332091,HG-0332091-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,IC50,610,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332069,HG-0332069-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,530.487,Cav1.2/CACNA2D1/CAB1,IC50,1030,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332085,HG-0332085-0-00,Clc1ccccc1C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,IC50,1100,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332093,HG-0332093-0-00,Fc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,478.6,Cav1.2/CACNA2D1/CAB1,IC50,1100,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332081,HG-0332081-0-00,Clc1cccc(c1)C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,IC50,1400,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332060,HG-0332060-0-00,COc1cc(cc(OC)c1OC)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,550.687,Cav1.2/CACNA2D1/CAB1,IC50,1400,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332078,HG-0332078-0-00,O=C(CN1CCN(CC1)C(c2ccccc2)c3ccccc3)N(c4ccccc4)c5ccccc5,461.597,Cav1.2/CACNA2D1/CAB1,IC50,1600,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332084,HG-0332084-0-00,COc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,490.635,Cav1.2/CACNA2D1/CAB1,IC50,1600,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332077,HG-0332077-0-00,FC(F)(F)c1cccc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,1800,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332076,HG-0332076-0-00,O=C(NC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5,461.597,Cav1.2/CACNA2D1/CAB1,IC50,1840,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332068,HG-0332068-0-00,Cc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,474.636,Cav1.2/CACNA2D1/CAB1,IC50,2500,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331139,HG-0331139-0-00,COc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccc(OC)cc5,520.661,Cav1.2/CACNA2D1/CAB1,IC50,2900,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332073,HG-0332073-0-00,Clc1ccc(cc1)C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,IC50,2900,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332087,HG-0332087-0-00,CN1CCC(CC1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccc(Cl)cc5,516.117,Cav1.2/CACNA2D1/CAB1,IC50,3100,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332076,HG-0332076-0-00,O=C(NC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5,461.597,Cav1.2/CACNA2D1/CAB1,IC50,3500,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332088,HG-0332088-0-00,Cc1ccc(C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5)c(C)c1,489.651,Cav1.2/CACNA2D1/CAB1,IC50,3800,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,4300,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332063,HG-0332063-0-00,FC(F)(F)c1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,6100,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331147,HG-0331147-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,6200,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332077,HG-0332077-0-00,FC(F)(F)c1cccc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,6600,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,6800,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,6900,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,7400,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332072,HG-0332072-0-00,Clc1cccc(C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5)c1Cl,530.487,Cav1.2/CACNA2D1/CAB1,IC50,7900,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331147,HG-0331147-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,8500,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332071,HG-0332071-0-00,Clc1ccc(C(N2CCN(CC(=O)N(c3ccccc3)c4ccccc4)CC2)c5ccccc5)c(Cl)c1,530.487,Cav1.2/CACNA2D1/CAB1,IC50,8600,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332083,HG-0332083-0-00,CN1CCCC(C1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,481.672,Cav1.2/CACNA2D1/CAB1,IC50,9300,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331142,HG-0331142-0-00,Cc1ccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c(C)c1,488.662,Cav1.2/CACNA2D1/CAB1,IC50,9600,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332094,HG-0332094-0-00,COc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccc(cc5)C(F)(F)F,558.633,Cav1.2/CACNA2D1/CAB1,IC50,10000,nM,>,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332067,HG-0332067-0-00,FC(F)(F)c1ccccc1C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,10000,nM,=,,,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332095,HG-0332095-0-00,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,588.821,Cav1.2/CACNA2D1/CAB1,IC50,10000,nM,>,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332062,HG-0332062-0-00,CN1CCC(CC1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccc(F)cc5,499.662,Cav1.2/CACNA2D1/CAB1,IC50,11000,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0311057,HG-0311057-0-00,O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5,460.609,Cav1.2/CACNA2D1/CAB1,IC50,12200,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332065,HG-0332065-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,IC50,17900,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332063,HG-0332063-0-00,FC(F)(F)c1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,19600,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332063,HG-0332063-0-00,FC(F)(F)c1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav1.2/CACNA2D1/CAB1,IC50,19600,nM,=,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332086,HG-0332086-0-00,CN1CCC(CN2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)CC1,405.576,Cav1.2/CACNA2D1/CAB1,IC50,30000,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0332097,HG-0332097-0-00,OC(=O)C1CN(CCN1C(=O)CC(c2ccccc2)c3ccccc3)C(c4ccccc4)c5ccccc5,504.619,Cav1.2/CACNA2D1/CAB1,IC50,37140,nM,=,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332074,HG-0332074-0-00,CN1CCC(CC1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,481.672,Cav1.2/CACNA2D1/CAB1,IC50,100000,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331148,HG-0331148-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,106000,nM,=,,,,patch clamp,Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,IC50,133000,nM,=,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332096,HG-0332096-0-00,CCOC(=O)C1CN(CCN1C(=O)CC(c2ccccc2)c3ccccc3)C(c4ccccc4)c5ccccc5,532.672,Cav1.2/CACNA2D1/CAB1,IC50,210000,nM,=,,,,patch clamp,Antagonist activity at alpha1C/alpha2delta/beta1b L-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332080,HG-0332080-0-00,Clc1cccc(C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5)c1Cl,530.487,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332066,HG-0332066-0-00,Clc1cccc(C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5)c1Cl,530.487,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332064,HG-0332064-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332092,HG-0332092-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331145,HG-0331145-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,529.499,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332075,HG-0332075-0-00,O=C(CN(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5,461.597,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332079,HG-0332079-0-00,O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC4CCNCC4)CC3,391.549,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332089,HG-0332089-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332065,HG-0332065-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331470,HG-0331470-0-00,Clc1cccc(Cl)c1C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,529.499,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332090,HG-0332090-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,530.487,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331144,HG-0331144-0-00,Clc1cccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c1Cl,529.499,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331140,HG-0331140-0-00,Clc1cc(Cl)cc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,529.499,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332091,HG-0332091-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331355,HG-0331355-0-00,Clc1ccc(cc1Cl)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,529.499,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332070,HG-0332070-0-00,Cc1ccc(C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5)c(C)c1,489.651,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332086,HG-0332086-0-00,CN1CCC(CN2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)CC1,405.576,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332074,HG-0332074-0-00,CN1CCC(CC1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,481.672,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332082,HG-0332082-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5,496.042,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332069,HG-0332069-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)NC(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,530.487,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0332061,HG-0332061-0-00,Cc1ccc(C(N2CCN(CC2)C(=O)CN(c3ccccc3)c4ccccc4)c5ccccc5)c(C)c1,489.651,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,<,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331148,HG-0331148-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav1.2/CACNA2D1/CAB1,Inhibition,10,%,=,,10,,other,Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method,HEK293,Homo sapiens,ChEMBL
HG-0331597,HG-0331597-0-00,CN1C(=O)C(C(=O)Nc2nncs2)c3cc4occc4cc13,314.319,Cav1.3,Activity,0,%,=,,10,,binding,Percentage binding to Ca2+ channel D at 10 uM,,Homo sapiens,ChEMBL
HG-0331597,HG-0331597-0-00,CN1C(=O)C(C(=O)Nc2nncs2)c3cc4occc4cc13,314.319,Cav1.3,Activity,0,%,=,,10,,binding,Percentage binding to dihydropyridine sensitive Ca2+ channel D at 10 uM,,Homo sapiens,ChEMBL
HG-0331892,HG-0331892-0-00,CCCn1cnc2c(NCc3ccc(C)s3)nc(NC(CC)CO)nc12,374.504,Cav1.3,EC50,100000,nM,>,,,,patch clamp,Agonist activity at L-type Cav1.3 expressed in tsA201 cell assessed as calcium current by whole-cell patch clamp method,tsA201,Homo sapiens,ChEMBL
HG-0260086,HG-0260086-0-00,CO\C(=C/1\C(C(=C(C)N=C1C)C(=O)OC)c2ccccc2[N+](=O)[O-])\O,346.335,Cav1.3,IC50,1350,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331889,HG-0331889-0-00,CC1(C)CC(=C2C(C=C(N=C2C1)c3ccccc3)c4ccccc4)O,329.435,Cav1.3,IC50,2800,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331891,HG-0331891-0-00,CCOC(=O)C1=C(NC(=C(C1c2ccccc2Cl)C(=O)Nc3ccccn3)C)c4ccc(cc4)n5c(C)nc6cnccc56,605.085,Cav1.3,IC50,6600,nM,=,,,,binding,Displacement of [3H]nitrendipine from L-type calcium channel of bovine frontal cortex membranes.,,Bos taurus,ChEMBL
HG-0331891,HG-0331891-0-00,CCOC(=O)C1=C(NC(=C(C1c2ccccc2Cl)C(=O)Nc3ccccn3)C)c4ccc(cc4)n5c(C)nc6cnccc56,605.085,Cav1.3,IC50,6800,nM,=,,,,binding,Displacement of [3H]desmethoxy-verapamil from L-type calcium channel of bovine frontal cortex membranes,,Bos taurus,ChEMBL
HG-0331902,HG-0331902-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(Cl)cc2)c3ccccc3)\O,353.842,Cav1.3,IC50,9300,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331913,HG-0331913-0-00,CCCC1=NC(=CC(/C/1=C(\O)/OCC)c2ccccc2)c3ccccc3,347.45,Cav1.3,IC50,9900,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331891,HG-0331891-0-00,CCOC(=O)C1=C(NC(=C(C1c2ccccc2Cl)C(=O)Nc3ccccn3)C)c4ccc(cc4)n5c(C)nc6cnccc56,605.085,Cav1.3,IC50,10000,nM,>,,,,binding,Displacement of [3H]-diltiazem from L-type calcium channel of bovine frontal cortex membranes.,,Bos taurus,ChEMBL
HG-0331907,HG-0331907-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccccc2)c3ccc(cc3)[N+](=O)[O-])\O,364.395,Cav1.3,IC50,12200,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331901,HG-0331901-0-00,CCO\C(=C/1\C(C=C(N=C1CC)c2ccccc2)c3ccccc3)\O,333.424,Cav1.3,IC50,12800,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331899,HG-0331899-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(C)cc2)c3cccs3)\O,339.451,Cav1.3,IC50,14900,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331912,HG-0331912-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(Cl)cc2)c3cccc(OC)c3)\O,383.868,Cav1.3,IC50,15100,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331906,HG-0331906-0-00,CC1=NC(=CC(/C/1=C(\O)/OCC=C)c2ccccc2)c3ccc(Cl)cc3,365.853,Cav1.3,IC50,18500,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331903,HG-0331903-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccccc2)c3ccccc3)\O,319.397,Cav1.3,IC50,18700,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331905,HG-0331905-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccccc2)c3ccc(C)cc3)\O,333.424,Cav1.3,IC50,20600,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0310515,HG-0310515-0-00,COc1ccc(CCN2C(CN(NS(=O)(=O)C)C2=O)c3ccc(OC)cc3)cc1,419.495,Cav1.3,IC50,23400,nM,=,,,,patch clamp,Inhibition of Cav1.3 expressed in CHO cells by patch-clamp technique,CHO,Homo sapiens,ChEMBL
HG-0331890,HG-0331890-0-00,OC1=C2C(C=C(N=C2CCC1)c3ccccc3)c4ccccc4,301.382,Cav1.3,IC50,24000,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331896,HG-0331896-0-00,COc1ccc(cc1)C2C=C(N=C(C)/C/2=C(/O)\SC(C)(C)C)c3ccccc3,393.542,Cav1.3,IC50,26800,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331894,HG-0331894-0-00,CC(=O)C1=C(C)NC(=CC1c2ccccc2)c3ccccc3,289.371,Cav1.3,IC50,27100,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331910,HG-0331910-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(Cl)cc2)c3ccc(Cl)cc3)\O,388.287,Cav1.3,IC50,28400,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331911,HG-0331911-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccccc2)c3ccc(OC)cc3)\O,349.423,Cav1.3,IC50,29800,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331888,HG-0331888-0-00,COc1ccc(OC)c(c1)n2c(N)nc3cc(ccc23)C(F)(F)F,337.296,Cav1.3,IC50,32000,nM,=,,,,other,Inhibition of voltage sensitive calcium channel of embryonic chick dorsal root ganglion (DRG) cells,,Gallus gallus,ChEMBL
HG-0331908,HG-0331908-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(C)cc2)c3ccccc3[N+](=O)[O-])\O,378.421,Cav1.3,IC50,44100,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331904,HG-0331904-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2occc2)c3ccc(C)cc3)\O,323.386,Cav1.3,IC50,55500,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331893,HG-0331893-0-00,CC1=NC(=CC(/C/1=C(\O)/SC(C)(C)C)c2ccc(C)cc2)c3ccccc3,377.542,Cav1.3,IC50,56200,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331909,HG-0331909-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(Cl)cc2)c3ccccc3[N+](=O)[O-])\O,398.84,Cav1.3,IC50,57100,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331897,HG-0331897-0-00,CC1=NC(=CC(/C/1=C(\O)/SC(C)(C)C)c2ccc(Br)cc2)c3ccc(C)cc3,456.438,Cav1.3,IC50,59600,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331900,HG-0331900-0-00,C\C(=C/c1ccccc1)\C2C=C(N=C(C)/C/2=C(/O)\SC(C)(C)C)c3ccccc3,403.58,Cav1.3,IC50,63100,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331895,HG-0331895-0-00,CC1=NC(=CC(/C/1=C(\O)/SC(C)(C)C)c2ccccc2)c3ccccc3,363.516,Cav1.3,IC50,95800,nM,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331898,HG-0331898-0-00,CC1=NC(=CC(/C/1=C(\O)/SC(C)(C)C)c2ccc(C)cc2)c3ccc(C)cc3,391.569,Cav1.3,IC50,100000,nM,>,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331912,HG-0331912-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(Cl)cc2)c3cccc(OC)c3)\O,383.868,Cav1.3,Inhibition,48,%,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331905,HG-0331905-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccccc2)c3ccc(C)cc3)\O,333.424,Cav1.3,Inhibition,43,%,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331899,HG-0331899-0-00,CCO\C(=C/1\C(C=C(N=C1C)c2ccc(C)cc2)c3cccs3)\O,339.451,Cav1.3,Inhibition,36,%,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0331889,HG-0331889-0-00,CC1(C)CC(=C2C(C=C(N=C2C1)c3ccccc3)c4ccccc4)O,329.435,Cav1.3,Inhibition,79,%,=,,,,other,Inhibition of human Cav1.3 channel in human SH-SY5Y cells assessed as 70 mM K+ induced calcium elevation compound treated 15 mins before stimulus by Fluo-4/AM assay,SH-SY5Y,Homo sapiens,ChEMBL
HG-0332063,HG-0332063-0-00,FC(F)(F)c1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,528.607,Cav2.1/CACNA2D1/CAB1,IC50,966,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332097,HG-0332097-0-00,OC(=O)C1CN(CCN1C(=O)CC(c2ccccc2)c3ccccc3)C(c4ccccc4)c5ccccc5,504.619,Cav2.1/CACNA2D1/CAB1,IC50,3383,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav2.1/CACNA2D1/CAB1,IC50,4500,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332096,HG-0332096-0-00,CCOC(=O)C1CN(CCN1C(=O)CC(c2ccccc2)c3ccccc3)C(c4ccccc4)c5ccccc5,532.672,Cav2.1/CACNA2D1/CAB1,IC50,5028,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332094,HG-0332094-0-00,COc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccc(cc5)C(F)(F)F,558.633,Cav2.1/CACNA2D1/CAB1,IC50,7590,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0332095,HG-0332095-0-00,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,588.821,Cav2.1/CACNA2D1/CAB1,IC50,7592,nM,=,,,,patch clamp,Antagonist activity at alpha1A/alpha2delta/beta1b P/Q-type calcium channel (unknown origin) expressed in HEK293 cells assessed as 0.1 Hz current frequency dependent channel blocking for 2 to 3 mins in presence of Ba2+ by whole-cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331334,HG-0331334-0-00,CC(C)c1ccc(CC(=O)NC(C)c2ccc(OCC(F)(F)F)cn2)cc1,380.404,Cav3.1,IC50,1.2,nM,=,,,,patch clamp,Inhibition of CaV 3.1 channel (unknown origin) expressed in HEK293 cells by FLEPR Ca2+ flux assay,HEK293,Homo sapiens,ChEMBL
HG-0331334,HG-0331334-0-00,CC(C)c1ccc(CC(=O)NC(C)c2ccc(OCC(F)(F)F)cn2)cc1,380.404,Cav3.1,IC50,1.2,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 (unknown origin) expressed in HEK293 cells assessed as calcium influx by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331424,HG-0331424-0-00,CC1CN(Cc2ccccc2F)c3ccccc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,4,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331415,HG-0331415-0-00,CC1CN(Cc2oc(cc2)C(F)(F)F)c3ccccc3C(C)N1C(=O)Nc4cccnc4,444.45,Cav3.1,IC50,4,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331145,HG-0331145-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,529.499,Cav3.1,IC50,4,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -80 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331403,HG-0331403-0-00,CC1CN(Cc2cccc(F)c2F)c3ccccc3C(C)N1C(=O)NCc4ccccc4,435.509,Cav3.1,IC50,5,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331440,HG-0331440-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)NCc4ccccc4,399.528,Cav3.1,IC50,5,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331469,HG-0331469-0-00,CC1CN(Cc2ccccc2)c3cc(F)ccc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,6,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331485,HG-0331485-0-00,CC1CN(Cc2oc(cc2)C(F)(F)F)c3ccccc3C(C)N1C(=O)NCc4ccccc4,457.488,Cav3.1,IC50,7,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331404,HG-0331404-0-00,CC1CN(Cc2ccccc2)c3nc(F)ccc3C(C)N1C(=O)NCc4ccccc4,418.506,Cav3.1,IC50,7,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331400,HG-0331400-0-00,CC1CN(Cc2cccc(F)c2)c3ccccc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,8,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331464,HG-0331464-0-00,COc1ccc(CNC(=O)N2C(C)CN(Cc3ccccc3)c4ccccc4C2C)cc1,429.554,Cav3.1,IC50,8,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309045,HG-0309045-0-00,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(Br)cc3,500.471,Cav3.1,IC50,8.17,nM,=,,,,patch clamp,Inhibition of T-type calcium channel subunit alpha-1G (unknown origin) expressed in HEK293 cells assessed as inactivation of channel current at holding potential of 30 to 100mV by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0309045,HG-0309045-0-00,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(Br)cc3,500.471,Cav3.1,IC50,8.17,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents at 1 uM by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0309045,HG-0309045-0-00,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(Br)cc3,500.471,Cav3.1,IC50,8.17,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331449,HG-0331449-0-00,CC1CN(Cc2ccccc2)c3cc(F)cc(F)c3C(C)N1C(=O)Nc4cccnc4,422.47,Cav3.1,IC50,12,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331472,HG-0331472-0-00,CC1CN(Cc2ccc(F)c(F)c2)c3ccccc3C(C)N1C(=O)Nc4cccnc4,422.47,Cav3.1,IC50,13,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331436,HG-0331436-0-00,CC1CN(Cc2cnc(s2)C(F)(F)F)c3ccccc3C(C)N1C(=O)NCc4ccccc4,474.542,Cav3.1,IC50,13,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331467,HG-0331467-0-00,COc1ccc(CNC(=O)N2C(C)CN(Cc3oc(cc3)C(F)(F)F)c4cnccc4C2C)cc1,488.502,Cav3.1,IC50,13,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331448,HG-0331448-0-00,CC1CN(Cc2ccccc2)c3ncccc3C(C)N1C(=O)NCc4ccccc4,400.516,Cav3.1,IC50,15,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331441,HG-0331441-0-00,CC1CN(Cc2ccccc2)c3nc(Cl)ccc3C(C)N1C(=O)NCc4ccccc4,434.961,Cav3.1,IC50,16,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331440,HG-0331440-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)NCc4ccccc4,399.528,Cav3.1,IC50,17,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331397,HG-0331397-0-00,CC1CN(Cc2ccccc2)c3nc(C)ccc3C(C)N1C(=O)NCc4ccccc4,414.543,Cav3.1,IC50,18,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331500,HG-0331500-0-00,CC1CN(Cc2ccccc2)c3cccc(F)c3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,20,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331433,HG-0331433-0-00,CC1CN(CC2CCCC2)c3ccccc3C(C)N1C(=O)Nc4cccnc4,378.51,Cav3.1,IC50,23,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331501,HG-0331501-0-00,CC(C)CCN1CC(C)N(C(C)c2ccccc12)C(=O)Nc3cccnc3,366.5,Cav3.1,IC50,23,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331476,HG-0331476-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)C4CCOCC4,378.507,Cav3.1,IC50,24,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331399,HG-0331399-0-00,CC1CN(Cc2ccc(F)cc2)c3ccccc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,25,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309468,HG-0309468-0-00,CC(C)(C)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C(F)C1,389.335,Cav3.1,IC50,25,nM,=,,,,patch clamp,Inhibition of human T-type Cav3.1 expressed in HEK293 cells at -80mV holding potential by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331455,HG-0331455-0-00,CC1CN(Cc2cccc(n2)C(F)(F)F)c3ccccc3C(C)N1C(=O)NCc4ccccc4,468.514,Cav3.1,IC50,25,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331478,HG-0331478-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)N4CCOCC4,379.495,Cav3.1,IC50,26,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331401,HG-0331401-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)NC4COC4,365.469,Cav3.1,IC50,26,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331419,HG-0331419-0-00,[2H]C([2H])(N1CC(C)N(C(C)c2ccccc12)C(=O)Nc3cccnc3)c4ccccc4,388.502,Cav3.1,IC50,27,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0327456,HG-0327456-0-00,Fc1ccc(NC(=O)N2N=C(CC2c3ccc(F)cc3)c4ccncc4)cc1,378.375,Cav3.1,IC50,29,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 (unknown origin) expressed in HEK293 cells assessed as calcium influx by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331438,HG-0331438-0-00,CC(C)CCN1CC(C)N(C(C)c2ccccc12)C(=O)CCc3cccnc3,379.538,Cav3.1,IC50,29,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331450,HG-0331450-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)CCc4cccnc4,399.528,Cav3.1,IC50,31,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331145,HG-0331145-0-00,Clc1ccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c(Cl)c1,529.499,Cav3.1,IC50,33,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -100 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331483,HG-0331483-0-00,CC1CN(Cc2cnc(s2)C(F)(F)F)c3ccccc3C(C)N1C(=O)Nc4cccnc4,461.503,Cav3.1,IC50,33,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331459,HG-0331459-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)Cc4cncs4,391.529,Cav3.1,IC50,34,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331463,HG-0331463-0-00,CC1CN(CCOC(C)(C)C)c2ccccc2C(C)N1C(=O)NCc3ccccc3,409.564,Cav3.1,IC50,35,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331142,HG-0331142-0-00,Cc1ccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c(C)c1,488.662,Cav3.1,IC50,35,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -100 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331143,HG-0331143-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2ccccc2F)CC1)c3ccc(F)cc3,414.531,Cav3.1,IC50,36,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331497,HG-0331497-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)CN4CCOCC4,393.522,Cav3.1,IC50,36,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331426,HG-0331426-0-00,CC1CN(Cc2oc(cc2)C(F)(F)F)c3cnccc3C(C)N1C(=O)NCc4ccccc4,458.476,Cav3.1,IC50,37,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331414,HG-0331414-0-00,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(F)cc(Cl)c2)CC1,383.888,Cav3.1,IC50,37,nM,=,,,,patch clamp,Inhibition of human CaV 3.1 by manual patch clamp assay,,Homo sapiens,ChEMBL
HG-0331414,HG-0331414-0-00,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(F)cc(Cl)c2)CC1,383.888,Cav3.1,IC50,37,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 (unknown origin) expressed in HEK293 cells assessed as calcium influx by Fluo-4-AM dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331451,HG-0331451-0-00,CC1CN(Cc2cccc(F)c2F)c3cnccc3C(C)N1C(=O)NCc4ccccc4,436.497,Cav3.1,IC50,38,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331405,HG-0331405-0-00,CC1CN(Cc2cnc(s2)C(F)(F)F)c3ccccc3C(C)N1C(=O)CCc4cccnc4,474.542,Cav3.1,IC50,40,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331425,HG-0331425-0-00,CC1CN(Cc2ccccc2)c3cccc(F)c3C(C)N1C(=O)NC4COC4,383.459,Cav3.1,IC50,40,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,41,nM,=,,,,other,Inhibition of T-type calcium channel alpha 1 G,,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,41,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha-1G subunit expressed in HEK293 cells assessed as calcium current by patch-clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,41,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,41.3,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331392,HG-0331392-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)Nc4cccnc4,386.489,Cav3.1,IC50,42,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309468,HG-0309468-0-00,CC(C)(C)CCN1CCC(CNC(=O)c2cc(Cl)cc(Cl)c2)C(F)C1,389.335,Cav3.1,IC50,43,nM,=,,,,patch clamp,Inhibition of human T-type Cav3.1 expressed in HEK293 cells at -100mV holding potential by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331452,HG-0331452-0-00,COc1ccc(CN2CC(C)N(C(C)c3ccccc23)C(=O)NCc4ccccc4)cn1,430.542,Cav3.1,IC50,45,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331420,HG-0331420-0-00,CC(C)CCN1CC(C)N(C(C)c2c(F)cccc12)C(=O)CCc3cccnc3,397.529,Cav3.1,IC50,45,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331432,HG-0331432-0-00,CC1CN(Cc2ccccc2)c3cccc(F)c3C(C)N1C(=O)CCc4cccnc4,417.518,Cav3.1,IC50,47,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331487,HG-0331487-0-00,CC1CN(Cc2ccccc2F)c3cnccc3C(C)N1C(=O)NCc4ccccc4,418.506,Cav3.1,IC50,47,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331474,HG-0331474-0-00,CC1CN(Cc2cccnc2F)c3ccccc3C(C)N1C(=O)NCc4ccccc4,418.506,Cav3.1,IC50,53,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331107,HG-0331107-0-00,COC(=O)C(CCCN(C)CCCc1nc2cc(C)c(C)cc2[nH]1)(C(C)C)c3ccc(Br)cc3,528.524,Cav3.1,IC50,53.02,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331147,HG-0331147-0-00,Clc1cccc(c1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav3.1,IC50,55,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -80 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0316625,HG-0316625-0-00,COC(=O)C(CCC(=O)N(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(Br)cc3,514.455,Cav3.1,IC50,56,nM,=,,,,patch clamp,Inhibition of T-type calcium channel subunit alpha-1G (unknown origin) expressed in HEK293 cells assessed as inactivation of channel current at holding potential of 30 to 100mV by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331442,HG-0331442-0-00,CC1CN(Cc2ccccc2)c3nc(ccc3C(C)N1C(=O)NCc4ccccc4)C(F)(F)F,468.514,Cav3.1,IC50,57,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331144,HG-0331144-0-00,Clc1cccc(C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5)c1Cl,529.499,Cav3.1,IC50,63,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -100 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331429,HG-0331429-0-00,CC1CN(Cc2ccccc2)c3ncc(F)cc3C(C)N1C(=O)NCc4ccccc4,418.506,Cav3.1,IC50,65,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331439,HG-0331439-0-00,CC1CN(Cc2ccccc2)c3ccc(F)cc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,68,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331394,HG-0331394-0-00,COc1ccc(CNC(=O)N2C(C)CN(CCC(C)C)c3cnccc3C2C)cc1,410.552,Cav3.1,IC50,76,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331466,HG-0331466-0-00,CC1CN(Cc2ccccc2)c3ncc(Cl)cc3C(C)N1C(=O)NCc4ccccc4,434.961,Cav3.1,IC50,78,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331446,HG-0331446-0-00,COc1ccc(CNC(=O)N2C(C)CN(Cc3ccccc3)c4cnccc4C2C)cc1,430.542,Cav3.1,IC50,79,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331141,HG-0331141-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav3.1,IC50,81,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -100 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331174,HG-0331174-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2ccc(F)cc2)CC1)c3ccc(F)cc3,414.531,Cav3.1,IC50,82,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331156,HG-0331156-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2ccccc2)CC1)c3ccc(F)cc3,396.541,Cav3.1,IC50,85,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331165,HG-0331165-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2ccccc2)CC1)c3ccc(F)cc3,410.567,Cav3.1,IC50,89,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0313032,HG-0313032-0-00,CC(NC(=O)Cc1ccc(cc1)C2CC2)c3ccc(OCC(F)(F)F)cn3,378.388,Cav3.1,IC50,89,nM,=,,,,patch clamp,Inhibition of Cav3.1 alpha1G at -80 mV holding potential by tandard voltage-clamp electrophysiology assay,,Homo sapiens,ChEMBL
HG-0331167,HG-0331167-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2ccccc2F)CC1)c3ccc(F)cc3,428.558,Cav3.1,IC50,90,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309291,HG-0309291-0-00,CC1(C)CC(CN2CCC(F)(CNC(=O)c3cc(Cl)cc(Cl)c3)CC2)CCO1,431.372,Cav3.1,IC50,93,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel Cav3.1 alpha-1G at -100 mV by voltage-clamp electrophysiology assay,,Homo sapiens,ChEMBL
HG-0331172,HG-0331172-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2cccc(OC)c2)CC1)c3ccc(F)cc3,426.567,Cav3.1,IC50,94,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0309574,HG-0309574-0-00,COC(=O)C(CCCN1CCN(CC1)c2ccccc2OC)(C(C)C)c3ccc(Br)cc3,503.472,Cav3.1,IC50,95,nM,=,,,,patch clamp,Inhibition of T-type calcium channel subunit alpha-1G (unknown origin) expressed in HEK293 cells assessed as inactivation of channel current at holding potential of 30 to 100mV by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331100,HG-0331100-0-00,CCOC(=O)C(CCCN(C)CCCc1nc2cc(C)c(C)cc2[nH]1)(C(C)C)c3ccccc3,463.655,Cav3.1,IC50,100,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0330861,HG-0330861-0-00,CCC1CCCCN1CCCNC(=O)c2ccc3C(=O)N(Cc4ccc(Cl)cc4)C(=S)Nc3c2,499.068,Cav3.1,IC50,100,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 with alpha-1G subunit by patch clamp assay,,Homo sapiens,ChEMBL
HG-0330861,HG-0330861-0-00,CCC1CCCCN1CCCNC(=O)c2ccc3C(=O)N(Cc4ccc(Cl)cc4)C(=S)Nc3c2,499.068,Cav3.1,IC50,100,nM,=,,,,patch clamp,Inhibition of alpha-1G T-type calcium channel expressed in HEK293 cells by electrophysiological method,HEK293,Homo sapiens,ChEMBL
HG-0315737,HG-0315737-0-00,OC(COc1ccc(F)cc1)CN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2,413.313,Cav3.1,IC50,100,nM,=,,,,patch clamp,Inhibition of alpha-1G calcium channel in human HEK293 cells by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331492,HG-0331492-0-00,CC1CN(Cc2ccccc2)c3ccccc3CN1C(=O)NCc4ccccc4,385.501,Cav3.1,IC50,102,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331395,HG-0331395-0-00,CC1CN(Cc2ccccc2)c3cncc(F)c3C(C)N1C(=O)Nc4cccnc4,405.468,Cav3.1,IC50,107,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331481,HG-0331481-0-00,CC1CN(CCOC(C)(C)C)c2ccccc2C(C)N1C(=O)Nc3cccnc3,396.526,Cav3.1,IC50,108,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331023,HG-0331023-0-00,Fc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,611.729,Cav3.1,IC50,110,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331023,HG-0331023-0-00,Fc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,611.729,Cav3.1,IC50,110,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331411,HG-0331411-0-00,CC1CN(Cc2cnc(s2)C(F)(F)F)c3cccc(F)c3C(C)N1C(=O)CCc4cccnc4,492.532,Cav3.1,IC50,115,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331175,HG-0331175-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2ccccc2OC)CC1)c3ccc(F)cc3,426.567,Cav3.1,IC50,120,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331168,HG-0331168-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2cccc(F)c2)CC1)c3ccc(F)cc3,428.558,Cav3.1,IC50,130,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331084,HG-0331084-0-00,NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,531.69,Cav3.1,IC50,130,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331084,HG-0331084-0-00,NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,531.69,Cav3.1,IC50,130,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 expressed in HEK293 cells co-expressing alpha1G subunit by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331155,HG-0331155-0-00,CC(C)(CNC(=O)C1CCN(Cc2ccccc2)CC1)c3ccc(F)cc3,368.488,Cav3.1,IC50,130,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331166,HG-0331166-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2cccc(F)c2)CC1)c3ccc(F)cc3,414.531,Cav3.1,IC50,130,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331084,HG-0331084-0-00,NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,531.69,Cav3.1,IC50,130.02,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331409,HG-0331409-0-00,CC1CN(Cc2ccccc2)c3cnccc3C(C)N1C(=O)NCc4ccccc4,400.516,Cav3.1,IC50,138,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330841,HG-0330841-0-00,NCCCCCN1C(CC(=O)NCc2ccccc2)c3ccccc3N=C1Nc4ccc(cc4)c5ccccc5,531.69,Cav3.1,IC50,139.96,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331412,HG-0331412-0-00,CC1CN(Cc2ccccc2)c3cncc(F)c3C(C)N1C(=O)NCc4ccccc4,418.506,Cav3.1,IC50,140,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330841,HG-0330841-0-00,NCCCCCN1C(CC(=O)NCc2ccccc2)c3ccccc3N=C1Nc4ccc(cc4)c5ccccc5,531.69,Cav3.1,IC50,140,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331170,HG-0331170-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2cccc(OC)c2)CC1)c3ccc(F)cc3,440.593,Cav3.1,IC50,140,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331148,HG-0331148-0-00,Clc1ccccc1C(N2CCN(CC2)C(=O)CC(c3ccccc3)c4ccccc4)c5ccccc5,495.054,Cav3.1,IC50,141,nM,=,,,,patch clamp,Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -80 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331409,HG-0331409-0-00,CC1CN(Cc2ccccc2)c3cnccc3C(C)N1C(=O)NCc4ccccc4,400.516,Cav3.1,IC50,142,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331272,HG-0331272-0-00,CC(C)(C)OC(=O)NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,159.96,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331272,HG-0331272-0-00,CC(C)(C)OC(=O)NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,160,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331272,HG-0331272-0-00,CC(C)(C)OC(=O)NCCCCCNC1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,160,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0330833,HG-0330833-0-00,Cc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,607.765,Cav3.1,IC50,169.82,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331028,HG-0331028-0-00,CC(C)(C)OC(=O)NCCCCCN1C(CC(=O)NCc2ccccc2)c3ccccc3N=C1Nc4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,169.82,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331176,HG-0331176-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2ccccc2OC)CC1)c3ccc(F)cc3,440.593,Cav3.1,IC50,170,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330833,HG-0330833-0-00,Cc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,607.765,Cav3.1,IC50,170,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331028,HG-0331028-0-00,CC(C)(C)OC(=O)NCCCCCN1C(CC(=O)NCc2ccccc2)c3ccccc3N=C1Nc4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,170,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331028,HG-0331028-0-00,CC(C)(C)OC(=O)NCCCCCN1C(CC(=O)NCc2ccccc2)c3ccccc3N=C1Nc4ccc(cc4)c5ccccc5,631.806,Cav3.1,IC50,170,nM,=,,,,other,Inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331393,HG-0331393-0-00,CC1CN(Cc2ccccc2)c3c(F)cccc3C(C)N1C(=O)Nc4cccnc4,404.48,Cav3.1,IC50,178,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331151,HG-0331151-0-00,CCC(CC)(CNC(=O)C1CCN(CCc2ccc(F)cc2)CC1)c3ccc(F)cc3,428.558,Cav3.1,IC50,180,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331489,HG-0331489-0-00,CC1CN(Cc2ccccc2)c3cc(OCC(F)(F)F)ccc3C(C)N1C(=O)Nc4cccnc4,484.513,Cav3.1,IC50,187,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331437,HG-0331437-0-00,COc1cccc2N(Cc3ccccc3)CC(C)N(C(C)c12)C(=O)Nc4cccnc4,416.515,Cav3.1,IC50,188,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331101,HG-0331101-0-00,COC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccc(OC)cc3,451.601,Cav3.1,IC50,190,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331266,HG-0331266-0-00,Clc1ccc(cc1)C(N2CCN(CC2)C(=O)CCCNCC3CCCCC3)c4ccccc4,468.074,Cav3.1,IC50,190,nM,=,,,,patch clamp,Inhibition of T-type alpha1G channel expressed in HEK293 cells by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331391,HG-0331391-0-00,CC1N(CCN(Cc2ccccc2)c3ccccc13)C(=O)NCc4ccccc4,385.501,Cav3.1,IC50,193,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331447,HG-0331447-0-00,CC1CN(Cc2ccccc2)c3cnccc3C(C)N1C(=O)CCc4ccc(F)cc4,417.518,Cav3.1,IC50,196,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331023,HG-0331023-0-00,Fc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,611.729,Cav3.1,IC50,200,nM,=,,,,patch clamp,Inhibition of alpha-1G T-type calcium channel expressed in HEK293 cells by electrophysiological method,HEK293,Homo sapiens,ChEMBL
HG-0331023,HG-0331023-0-00,Fc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,611.729,Cav3.1,IC50,200,nM,=,,,,other,Concentration of the compounds required for inhibition of HEK293 cells (alpha1G T-type),HEK293,Homo sapiens,ChEMBL
HG-0331173,HG-0331173-0-00,CCC(CC)(CNC(=O)C1CCN(Cc2ccc(OC)cc2)CC1)c3ccc(F)cc3,426.567,Cav3.1,IC50,200,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0206889,HG-0206889-0-00,COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc4cc(F)ccc4C1C(C)C,495.629,Cav3.1,IC50,200,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331402,HG-0331402-0-00,CC1CN(C(C)c2ccccc2N1Cc3ccccc3)C(=O)NCc4ccccc4,399.528,Cav3.1,IC50,211,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331494,HG-0331494-0-00,CC1CN(Cc2ccccc2)c3cnc(Cl)cc3C(C)N1C(=O)NCc4ccccc4,434.961,Cav3.1,IC50,220,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331149,HG-0331149-0-00,Fc1ccc(cc1)C2(CNC(=O)C3CCN(Cc4ccccc4)CC3)CCCC2,394.525,Cav3.1,IC50,220,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331406,HG-0331406-0-00,CC1CN(Cc2ccccc2)c3cc(C)ccc3C(C)N1C(=O)Nc4cccnc4,400.516,Cav3.1,IC50,227,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0315737,HG-0315737-0-00,OC(COc1ccc(F)cc1)CN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2,413.313,Cav3.1,IC50,230,nM,=,,,,patch clamp,Inhibition of alpha-1G calcium channel in human HEK293 cells by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331082,HG-0331082-0-00,COC(=O)CC1N(C(=Nc2ccccc12)N(C)CCCCCN(C)C)c3ccc(cc3)c4ccccc4,498.659,Cav3.1,IC50,230,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha-1G subunit expressed in HEK293 cells assessed as calcium current by patch-clamp assay,HEK293,Homo sapiens,ChEMBL
HG-0331082,HG-0331082-0-00,COC(=O)CC1N(C(=Nc2ccccc12)N(C)CCCCCN(C)C)c3ccc(cc3)c4ccccc4,498.659,Cav3.1,IC50,230,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331082,HG-0331082-0-00,COC(=O)CC1N(C(=Nc2ccccc12)N(C)CCCCCN(C)C)c3ccc(cc3)c4ccccc4,498.659,Cav3.1,IC50,230.14,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331157,HG-0331157-0-00,CCC(CC)(CNC(=O)C1CCN(CCCc2ccccc2)CC1)c3ccc(F)cc3,424.594,Cav3.1,IC50,240,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331337,HG-0331337-0-00,CCC(CC)(CNC(=O)C1CCN(CCCCc2ccccc2)CC1)c3ccc(F)cc3,438.62,Cav3.1,IC50,250,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331103,HG-0331103-0-00,CCOC(=O)C(CCCN(C)CCCc1nc2ccccc2[nH]1)(C(C)C)c3ccccc3,435.602,Cav3.1,IC50,250,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331105,HG-0331105-0-00,COC(=O)C(CCCN(C)CCCc1nc2cc(OC)ccc2[nH]1)(C(C)C)c3ccc(Br)cc3,530.497,Cav3.1,IC50,250,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0330833,HG-0330833-0-00,Cc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,607.765,Cav3.1,IC50,250,nM,=,,,,other,Concentration of the compounds required for inhibition of HEK293 cells (alpha1G T-type),HEK293,Homo sapiens,ChEMBL
HG-0330833,HG-0330833-0-00,Cc1ccc(cc1)S(=O)(=O)Nc2ccc(CNC(=O)CC3N(C(=Nc4ccccc34)N5CCCCC5)c6ccccc6)cc2,607.765,Cav3.1,IC50,250,nM,=,,,,patch clamp,Inhibition of alpha-1G T-type calcium channel expressed in HEK293 cells by electrophysiological method,HEK293,Homo sapiens,ChEMBL
HG-0331484,HG-0331484-0-00,CC1CN(c2ccccc2)c3ccccc3C(C)N1C(=O)NCc4ccccc4,385.501,Cav3.1,IC50,256,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,260,nM,=,,,,patch clamp,Inhibition of T-type CaV3.1 channel (unknown origin) expressed in HEK293 cells assessed as inhibition of calcium current by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331495,HG-0331495-0-00,[2H]C([2H])(N1CC(C)N(C(C)c2ccncc12)C(=O)NCc3ccccc3)c4ccccc4,402.528,Cav3.1,IC50,260,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331158,HG-0331158-0-00,CCC(CC)(CNC(=O)C1CCN(CCOc2ccccc2)CC1)c3ccc(F)cc3,426.567,Cav3.1,IC50,260,nM,=,,,,patch clamp,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0330832,HG-0330832-0-00,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc3ccccc3)N1c4ccc(cc4)c5ccccc5,573.77,Cav3.1,IC50,260,nM,=,,,,patch clamp,Inhibition of t-type Cav3.1 channel (unknown origin) expressed in HEK293 cells assessed as inhibition of 50 ms depolarizing voltage step-induced current by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331112,HG-0331112-0-00,CCOC(=O)C(CCCN1CCN(Cc2ccc(F)cc2)CC1)(C(C)C)c3ccccc3,440.593,Cav3.1,IC50,260,nM,=,,,,patch clamp,Antagonist activity at T type calcium channel alpha1G expressed in HEK293 cells assessed as inhibition of peak currents by whole-cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331022,HG-0331022-0-00,CN(CCCCCN1CCCC1)C2=Nc3ccccc3C(CC(=O)NCc4ccccc4)N2c5ccc(cc5)c6ccccc6,599.807,Cav3.1,IC50,260,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 expressed in HEK293 cells co-expressing alpha1G subunit by whole-cell patch clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331022,HG-0331022-0-00,CN(CCCCCN1CCCC1)C2=Nc3ccccc3C(CC(=O)NCc4ccccc4)N2c5ccc(cc5)c6ccccc6,599.807,Cav3.1,IC50,260,nM,=,,,,patch clamp,Inhibition of T-type calcium channel Cav3.1 alpha1G expressed in HEK293 cells by whole cell patch-clamp method,HEK293,Homo sapiens,ChEMBL
HG-0331022,HG-0331022-0-00,CN(CCCCCN1CCCC1)C2=Nc3ccccc3C(CC(=O)NCc4ccccc4)N2c5ccc(cc5)c6ccccc6,599.807,Cav3.1,IC50,260.02,nM,=,,,,other,Inhibition of human T-type calcium channel alpha1G in HEK293 cells,HEK293,Homo sapiens,ChEMBL
HG-0331440,HG-0331440-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)NCc4ccccc4,399.528,Cav3.1,IC50,262,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL
HG-0331440,HG-0331440-0-00,CC1CN(Cc2ccccc2)c3ccccc3C(C)N1C(=O)NCc4ccccc4,399.528,Cav3.1,IC50,279,nM,=,,,,patch clamp,Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins followed by CaCl2 addition by fluo-4 dye-based FLIPR assay,HEK293,Homo sapiens,ChEMBL